id	sid	tid	token	lemma	pos
work_sveky7445vfatkdfpzvurqbhza	1	1	HP5	hp5	IN
work_sveky7445vfatkdfpzvurqbhza	1	2	THE	the	DT
work_sveky7445vfatkdfpzvurqbhza	1	3	RELATIONSHIP	relationship	NN
work_sveky7445vfatkdfpzvurqbhza	1	4	OF	of	IN
work_sveky7445vfatkdfpzvurqbhza	1	5	DIRECT	direct	NN
work_sveky7445vfatkdfpzvurqbhza	1	6	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	1	7	TO	to	IN
work_sveky7445vfatkdfpzvurqbhza	1	8	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	1	9	CONSUMER	consumer	NN
work_sveky7445vfatkdfpzvurqbhza	1	10	ADVERTISING	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	1	11	AND	and	CC
work_sveky7445vfatkdfpzvurqbhza	1	12	CLINICIAN	clinician	NN
work_sveky7445vfatkdfpzvurqbhza	1	13	BEHAVIORAL	BEHAVIORAL	NNS
work_sveky7445vfatkdfpzvurqbhza	1	14	INTENTIONS	intentions	NN
work_sveky7445vfatkdfpzvurqbhza	1	15	132	132	CD
work_sveky7445vfatkdfpzvurqbhza	1	16	Abstracts	abstract	NNS
work_sveky7445vfatkdfpzvurqbhza	1	17	used	use	VBN
work_sveky7445vfatkdfpzvurqbhza	1	18	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	1	19	apply	apply	VB
work_sveky7445vfatkdfpzvurqbhza	1	20	hospital-	hospital-	NN
work_sveky7445vfatkdfpzvurqbhza	1	21	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	1	22	revenue	revenue	NN
work_sveky7445vfatkdfpzvurqbhza	1	23	center	center	NN
work_sveky7445vfatkdfpzvurqbhza	1	24	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	1	25	specific	specific	JJ
work_sveky7445vfatkdfpzvurqbhza	1	26	cost	cost	NN
work_sveky7445vfatkdfpzvurqbhza	1	27	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	1	28	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	1	29	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	1	30	charge	charge	NN
work_sveky7445vfatkdfpzvurqbhza	1	31	ratios	ratio	NNS
work_sveky7445vfatkdfpzvurqbhza	1	32	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	1	33	estimate	estimate	VB
work_sveky7445vfatkdfpzvurqbhza	1	34	pharmaceutical	pharmaceutical	JJ
work_sveky7445vfatkdfpzvurqbhza	1	35	costs	cost	NNS
work_sveky7445vfatkdfpzvurqbhza	1	36	from	from	IN
work_sveky7445vfatkdfpzvurqbhza	1	37	charges	charge	NNS
work_sveky7445vfatkdfpzvurqbhza	1	38	at	at	IN
work_sveky7445vfatkdfpzvurqbhza	1	39	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	1	40	discharge	discharge	NN
work_sveky7445vfatkdfpzvurqbhza	1	41	level	level	NN
work_sveky7445vfatkdfpzvurqbhza	1	42	.	.	.
work_sveky7445vfatkdfpzvurqbhza	2	1	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	2	2	Diagnosis-	Diagnosis-	NNP
work_sveky7445vfatkdfpzvurqbhza	2	3	Related	Related	NNP
work_sveky7445vfatkdfpzvurqbhza	2	4	Group	Group	NNP
work_sveky7445vfatkdfpzvurqbhza	2	5	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	2	6	DRG	DRG	NNP
work_sveky7445vfatkdfpzvurqbhza	2	7	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	2	8	methodology	methodology	NN
work_sveky7445vfatkdfpzvurqbhza	2	9	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	2	10	used	use	VBN
work_sveky7445vfatkdfpzvurqbhza	2	11	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	2	12	case	case	NN
work_sveky7445vfatkdfpzvurqbhza	2	13	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	2	14	mix	mix	NN
work_sveky7445vfatkdfpzvurqbhza	2	15	adjust	adjust	VB
work_sveky7445vfatkdfpzvurqbhza	2	16	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	2	17	results	result	NNS
work_sveky7445vfatkdfpzvurqbhza	2	18	.	.	.
work_sveky7445vfatkdfpzvurqbhza	3	1	Relative	relative	JJ
work_sveky7445vfatkdfpzvurqbhza	3	2	value	value	NN
work_sveky7445vfatkdfpzvurqbhza	3	3	units	unit	NNS
work_sveky7445vfatkdfpzvurqbhza	3	4	were	be	VBD
work_sveky7445vfatkdfpzvurqbhza	3	5	derived	derive	VBN
work_sveky7445vfatkdfpzvurqbhza	3	6	from	from	IN
work_sveky7445vfatkdfpzvurqbhza	3	7	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	3	8	hospital	hospital	NN
work_sveky7445vfatkdfpzvurqbhza	3	9	specific	specific	JJ
work_sveky7445vfatkdfpzvurqbhza	3	10	cost	cost	NN
work_sveky7445vfatkdfpzvurqbhza	3	11	estimates	estimate	NNS
work_sveky7445vfatkdfpzvurqbhza	3	12	.	.	.
work_sveky7445vfatkdfpzvurqbhza	4	1	After	after	IN
work_sveky7445vfatkdfpzvurqbhza	4	2	trimming	trim	VBG
work_sveky7445vfatkdfpzvurqbhza	4	3	at	at	IN
work_sveky7445vfatkdfpzvurqbhza	4	4	+	+	RB
work_sveky7445vfatkdfpzvurqbhza	4	5	/-	/-	.
work_sveky7445vfatkdfpzvurqbhza	4	6	three	three	CD
work_sveky7445vfatkdfpzvurqbhza	4	7	standard	standard	JJ
work_sveky7445vfatkdfpzvurqbhza	4	8	deviations	deviation	NNS
work_sveky7445vfatkdfpzvurqbhza	4	9	,	,	,
work_sveky7445vfatkdfpzvurqbhza	4	10	cluster	cluster	VBD
work_sveky7445vfatkdfpzvurqbhza	4	11	analyses	analysis	NNS
work_sveky7445vfatkdfpzvurqbhza	4	12	methods	method	NNS
work_sveky7445vfatkdfpzvurqbhza	4	13	were	be	VBD
work_sveky7445vfatkdfpzvurqbhza	4	14	applied	apply	VBN
work_sveky7445vfatkdfpzvurqbhza	4	15	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	4	16	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	4	17	hospitals	hospital	NNS
work_sveky7445vfatkdfpzvurqbhza	4	18	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	4	19	allocate	allocate	VB
work_sveky7445vfatkdfpzvurqbhza	4	20	each	each	DT
work_sveky7445vfatkdfpzvurqbhza	4	21	hospital	hospital	NN
work_sveky7445vfatkdfpzvurqbhza	4	22	into	into	IN
work_sveky7445vfatkdfpzvurqbhza	4	23	one	one	CD
work_sveky7445vfatkdfpzvurqbhza	4	24	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	4	25	four	four	CD
work_sveky7445vfatkdfpzvurqbhza	4	26	levels	level	NNS
work_sveky7445vfatkdfpzvurqbhza	4	27	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	4	28	pharmaceutical	pharmaceutical	JJ
work_sveky7445vfatkdfpzvurqbhza	4	29	service	service	NN
work_sveky7445vfatkdfpzvurqbhza	4	30	intensity	intensity	NN
work_sveky7445vfatkdfpzvurqbhza	4	31	.	.	.
work_sveky7445vfatkdfpzvurqbhza	5	1	RESULTS	RESULTS	NNP
work_sveky7445vfatkdfpzvurqbhza	5	2	:	:	:
work_sveky7445vfatkdfpzvurqbhza	5	3	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	5	4	data	datum	NNS
work_sveky7445vfatkdfpzvurqbhza	5	5	set	set	NN
work_sveky7445vfatkdfpzvurqbhza	5	6	included	include	VBD
work_sveky7445vfatkdfpzvurqbhza	5	7	959	959	CD
work_sveky7445vfatkdfpzvurqbhza	5	8	acute	acute	JJ
work_sveky7445vfatkdfpzvurqbhza	5	9	care	care	NN
work_sveky7445vfatkdfpzvurqbhza	5	10	hospi-	hospi-	NN
work_sveky7445vfatkdfpzvurqbhza	5	11	tals	tal	NNS
work_sveky7445vfatkdfpzvurqbhza	5	12	,	,	,
work_sveky7445vfatkdfpzvurqbhza	5	13	representing	represent	VBG
work_sveky7445vfatkdfpzvurqbhza	5	14	inpatient	inpatient	NN
work_sveky7445vfatkdfpzvurqbhza	5	15	pharmacy	pharmacy	NN
work_sveky7445vfatkdfpzvurqbhza	5	16	cost	cost	VBD
work_sveky7445vfatkdfpzvurqbhza	5	17	information	information	NN
work_sveky7445vfatkdfpzvurqbhza	5	18	on	on	IN
work_sveky7445vfatkdfpzvurqbhza	5	19	more	more	JJR
work_sveky7445vfatkdfpzvurqbhza	5	20	than	than	IN
work_sveky7445vfatkdfpzvurqbhza	5	21	6.9	6.9	CD
work_sveky7445vfatkdfpzvurqbhza	5	22	million	million	CD
work_sveky7445vfatkdfpzvurqbhza	5	23	discharges	discharge	NNS
work_sveky7445vfatkdfpzvurqbhza	5	24	.	.	.
work_sveky7445vfatkdfpzvurqbhza	6	1	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	6	2	time	time	NN
work_sveky7445vfatkdfpzvurqbhza	6	3	period	period	NN
work_sveky7445vfatkdfpzvurqbhza	6	4	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	6	5	federal	federal	JJ
work_sveky7445vfatkdfpzvurqbhza	6	6	fiscal	fiscal	JJ
work_sveky7445vfatkdfpzvurqbhza	6	7	year	year	NN
work_sveky7445vfatkdfpzvurqbhza	6	8	2000	2000	CD
work_sveky7445vfatkdfpzvurqbhza	6	9	.	.	.
work_sveky7445vfatkdfpzvurqbhza	7	1	DRG	DRG	NNP
work_sveky7445vfatkdfpzvurqbhza	7	2	495	495	CD
work_sveky7445vfatkdfpzvurqbhza	7	3	,	,	,
work_sveky7445vfatkdfpzvurqbhza	7	4	lung	lung	NN
work_sveky7445vfatkdfpzvurqbhza	7	5	transplant	transplant	NN
work_sveky7445vfatkdfpzvurqbhza	7	6	,	,	,
work_sveky7445vfatkdfpzvurqbhza	7	7	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	7	8	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	7	9	most	most	RBS
work_sveky7445vfatkdfpzvurqbhza	7	10	costly	costly	JJ
work_sveky7445vfatkdfpzvurqbhza	7	11	group	group	NN
work_sveky7445vfatkdfpzvurqbhza	7	12	,	,	,
work_sveky7445vfatkdfpzvurqbhza	7	13	while	while	IN
work_sveky7445vfatkdfpzvurqbhza	7	14	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	7	15	least	least	JJS
work_sveky7445vfatkdfpzvurqbhza	7	16	costly	costly	JJ
work_sveky7445vfatkdfpzvurqbhza	7	17	group	group	NN
work_sveky7445vfatkdfpzvurqbhza	7	18	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	7	19	DRG	DRG	NNP
work_sveky7445vfatkdfpzvurqbhza	7	20	391	391	CD
work_sveky7445vfatkdfpzvurqbhza	7	21	,	,	,
work_sveky7445vfatkdfpzvurqbhza	7	22	normal	normal	JJ
work_sveky7445vfatkdfpzvurqbhza	7	23	newborn	newborn	JJ
work_sveky7445vfatkdfpzvurqbhza	7	24	.	.	.
work_sveky7445vfatkdfpzvurqbhza	8	1	Of	of	IN
work_sveky7445vfatkdfpzvurqbhza	8	2	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	8	3	959	959	CD
work_sveky7445vfatkdfpzvurqbhza	8	4	hospitals	hospital	NNS
work_sveky7445vfatkdfpzvurqbhza	8	5	,	,	,
work_sveky7445vfatkdfpzvurqbhza	8	6	11	11	CD
work_sveky7445vfatkdfpzvurqbhza	8	7	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	8	8	1.15	1.15	CD
work_sveky7445vfatkdfpzvurqbhza	8	9	%	%	NN
work_sveky7445vfatkdfpzvurqbhza	8	10	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	8	11	were	be	VBD
work_sveky7445vfatkdfpzvurqbhza	8	12	excluded	exclude	VBN
work_sveky7445vfatkdfpzvurqbhza	8	13	after	after	IN
work_sveky7445vfatkdfpzvurqbhza	8	14	trimming	trim	VBG
work_sveky7445vfatkdfpzvurqbhza	8	15	on	on	IN
work_sveky7445vfatkdfpzvurqbhza	8	16	intensity	intensity	NN
work_sveky7445vfatkdfpzvurqbhza	8	17	score	score	NN
work_sveky7445vfatkdfpzvurqbhza	8	18	.	.	.
work_sveky7445vfatkdfpzvurqbhza	9	1	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	9	2	mean	mean	JJ
work_sveky7445vfatkdfpzvurqbhza	9	3	relative	relative	JJ
work_sveky7445vfatkdfpzvurqbhza	9	4	value	value	NN
work_sveky7445vfatkdfpzvurqbhza	9	5	score	score	NN
work_sveky7445vfatkdfpzvurqbhza	9	6	for	for	IN
work_sveky7445vfatkdfpzvurqbhza	9	7	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	9	8	remaining	remain	VBG
work_sveky7445vfatkdfpzvurqbhza	9	9	948	948	CD
work_sveky7445vfatkdfpzvurqbhza	9	10	hospitals	hospital	NNS
work_sveky7445vfatkdfpzvurqbhza	9	11	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	9	12	2.77	2.77	CD
work_sveky7445vfatkdfpzvurqbhza	9	13	,	,	,
work_sveky7445vfatkdfpzvurqbhza	9	14	with	with	IN
work_sveky7445vfatkdfpzvurqbhza	9	15	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	9	16	range	range	NN
work_sveky7445vfatkdfpzvurqbhza	9	17	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	9	18	1.17	1.17	CD
work_sveky7445vfatkdfpzvurqbhza	9	19	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	9	20	5.02	5.02	CD
work_sveky7445vfatkdfpzvurqbhza	9	21	.	.	.
work_sveky7445vfatkdfpzvurqbhza	10	1	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	10	2	standard	standard	JJ
work_sveky7445vfatkdfpzvurqbhza	10	3	deviation	deviation	NN
work_sveky7445vfatkdfpzvurqbhza	10	4	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	10	5	0.59	0.59	CD
work_sveky7445vfatkdfpzvurqbhza	10	6	.	.	.
work_sveky7445vfatkdfpzvurqbhza	11	1	CONCLUSIONS	conclusion	NNS
work_sveky7445vfatkdfpzvurqbhza	11	2	:	:	:
work_sveky7445vfatkdfpzvurqbhza	11	3	These	these	DT
work_sveky7445vfatkdfpzvurqbhza	11	4	results	result	NNS
work_sveky7445vfatkdfpzvurqbhza	11	5	provide	provide	VBP
work_sveky7445vfatkdfpzvurqbhza	11	6	empirical	empirical	JJ
work_sveky7445vfatkdfpzvurqbhza	11	7	evidence	evidence	NN
work_sveky7445vfatkdfpzvurqbhza	11	8	from	from	IN
work_sveky7445vfatkdfpzvurqbhza	11	9	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	11	10	very	very	RB
work_sveky7445vfatkdfpzvurqbhza	11	11	large	large	JJ
work_sveky7445vfatkdfpzvurqbhza	11	12	sample	sample	NN
work_sveky7445vfatkdfpzvurqbhza	11	13	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	11	14	hospitals	hospital	NNS
work_sveky7445vfatkdfpzvurqbhza	11	15	that	that	IN
work_sveky7445vfatkdfpzvurqbhza	11	16	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	11	17	intensity	intensity	NN
work_sveky7445vfatkdfpzvurqbhza	11	18	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	11	19	pharmaceutical	pharmaceutical	JJ
work_sveky7445vfatkdfpzvurqbhza	11	20	interventions	intervention	NNS
work_sveky7445vfatkdfpzvurqbhza	11	21	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	11	22	acute	acute	JJ
work_sveky7445vfatkdfpzvurqbhza	11	23	care	care	NN
work_sveky7445vfatkdfpzvurqbhza	11	24	hospitals	hospital	NNS
work_sveky7445vfatkdfpzvurqbhza	11	25	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	11	26	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	11	27	U.S.	U.S.	NNP
work_sveky7445vfatkdfpzvurqbhza	11	28	exhibits	exhibit	VBZ
work_sveky7445vfatkdfpzvurqbhza	11	29	considerable	considerable	JJ
work_sveky7445vfatkdfpzvurqbhza	11	30	variability	variability	NN
work_sveky7445vfatkdfpzvurqbhza	11	31	.	.	.
work_sveky7445vfatkdfpzvurqbhza	12	1	A	a	DT
work_sveky7445vfatkdfpzvurqbhza	12	2	four	four	CD
work_sveky7445vfatkdfpzvurqbhza	12	3	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	12	4	fold	fold	JJ
work_sveky7445vfatkdfpzvurqbhza	12	5	difference	difference	NN
work_sveky7445vfatkdfpzvurqbhza	12	6	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	12	7	detected	detect	VBN
work_sveky7445vfatkdfpzvurqbhza	12	8	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	12	9	intensity	intensity	NN
work_sveky7445vfatkdfpzvurqbhza	12	10	score	score	NN
work_sveky7445vfatkdfpzvurqbhza	12	11	between	between	IN
work_sveky7445vfatkdfpzvurqbhza	12	12	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	12	13	lowest	low	JJS
work_sveky7445vfatkdfpzvurqbhza	12	14	intensity	intensity	NN
work_sveky7445vfatkdfpzvurqbhza	12	15	hospitals	hospital	NNS
work_sveky7445vfatkdfpzvurqbhza	12	16	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	12	17	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	12	18	highest	high	JJS
work_sveky7445vfatkdfpzvurqbhza	12	19	.	.	.
work_sveky7445vfatkdfpzvurqbhza	13	1	This	this	DT
work_sveky7445vfatkdfpzvurqbhza	13	2	DRG	drg	NN
work_sveky7445vfatkdfpzvurqbhza	13	3	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	13	4	adjusted	adjust	VBN
work_sveky7445vfatkdfpzvurqbhza	13	5	difference	difference	NN
work_sveky7445vfatkdfpzvurqbhza	13	6	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	13	7	not	not	RB
work_sveky7445vfatkdfpzvurqbhza	13	8	due	due	JJ
work_sveky7445vfatkdfpzvurqbhza	13	9	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	13	10	differences	difference	NNS
work_sveky7445vfatkdfpzvurqbhza	13	11	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	13	12	case	case	NN
work_sveky7445vfatkdfpzvurqbhza	13	13	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	13	14	mix	mix	NN
work_sveky7445vfatkdfpzvurqbhza	13	15	across	across	IN
work_sveky7445vfatkdfpzvurqbhza	13	16	hospitals	hospital	NNS
work_sveky7445vfatkdfpzvurqbhza	13	17	.	.	.
work_sveky7445vfatkdfpzvurqbhza	14	1	Further	further	JJ
work_sveky7445vfatkdfpzvurqbhza	14	2	research	research	NN
work_sveky7445vfatkdfpzvurqbhza	14	3	should	should	MD
work_sveky7445vfatkdfpzvurqbhza	14	4	be	be	VB
work_sveky7445vfatkdfpzvurqbhza	14	5	done	do	VBN
work_sveky7445vfatkdfpzvurqbhza	14	6	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	14	7	determine	determine	VB
work_sveky7445vfatkdfpzvurqbhza	14	8	whether	whether	IN
work_sveky7445vfatkdfpzvurqbhza	14	9	patient	patient	JJ
work_sveky7445vfatkdfpzvurqbhza	14	10	outcomes	outcome	NNS
work_sveky7445vfatkdfpzvurqbhza	14	11	are	be	VBP
work_sveky7445vfatkdfpzvurqbhza	14	12	associated	associate	VBN
work_sveky7445vfatkdfpzvurqbhza	14	13	with	with	IN
work_sveky7445vfatkdfpzvurqbhza	14	14	low	low	JJ
work_sveky7445vfatkdfpzvurqbhza	14	15	versus	versus	IN
work_sveky7445vfatkdfpzvurqbhza	14	16	high	high	JJ
work_sveky7445vfatkdfpzvurqbhza	14	17	pharmaceutical	pharmaceutical	JJ
work_sveky7445vfatkdfpzvurqbhza	14	18	service	service	NN
work_sveky7445vfatkdfpzvurqbhza	14	19	intensity	intensity	NN
work_sveky7445vfatkdfpzvurqbhza	14	20	.	.	.
work_sveky7445vfatkdfpzvurqbhza	15	1	MI8	mi8	JJ
work_sveky7445vfatkdfpzvurqbhza	15	2	DEVELOPING	develop	VBG
work_sveky7445vfatkdfpzvurqbhza	15	3	A	a	DT
work_sveky7445vfatkdfpzvurqbhza	15	4	QUALITY	quality	JJ
work_sveky7445vfatkdfpzvurqbhza	15	5	APPRAISAL	appraisal	NN
work_sveky7445vfatkdfpzvurqbhza	15	6	INSTRUMENT	instrument	NN
work_sveky7445vfatkdfpzvurqbhza	15	7	TO	to	IN
work_sveky7445vfatkdfpzvurqbhza	15	8	EVALUATE	EVALUATE	NNP
work_sveky7445vfatkdfpzvurqbhza	15	9	THE	the	DT
work_sveky7445vfatkdfpzvurqbhza	15	10	PEDIATRIC	pediatric	JJ
work_sveky7445vfatkdfpzvurqbhza	15	11	HEALTH	health	NN
work_sveky7445vfatkdfpzvurqbhza	15	12	ECONOMICS	economic	NNS
work_sveky7445vfatkdfpzvurqbhza	15	13	LITERATURE	literature	NN
work_sveky7445vfatkdfpzvurqbhza	15	14	Ungar	Ungar	NNP
work_sveky7445vfatkdfpzvurqbhza	15	15	WJ1	WJ1	NNP
work_sveky7445vfatkdfpzvurqbhza	15	16	,	,	,
work_sveky7445vfatkdfpzvurqbhza	15	17	Menon	Menon	NNP
work_sveky7445vfatkdfpzvurqbhza	15	18	D2	D2	NNP
work_sveky7445vfatkdfpzvurqbhza	15	19	,	,	,
work_sveky7445vfatkdfpzvurqbhza	15	20	Lee	Lee	NNP
work_sveky7445vfatkdfpzvurqbhza	15	21	A1	A1	NNP
work_sveky7445vfatkdfpzvurqbhza	15	22	,	,	,
work_sveky7445vfatkdfpzvurqbhza	15	23	Stafinski	Stafinski	NNP
work_sveky7445vfatkdfpzvurqbhza	15	24	T2	t2	NN
work_sveky7445vfatkdfpzvurqbhza	15	25	1The	1the	CD
work_sveky7445vfatkdfpzvurqbhza	15	26	Hospital	Hospital	NNP
work_sveky7445vfatkdfpzvurqbhza	15	27	for	for	IN
work_sveky7445vfatkdfpzvurqbhza	15	28	Sick	Sick	NNP
work_sveky7445vfatkdfpzvurqbhza	15	29	Children	Children	NNP
work_sveky7445vfatkdfpzvurqbhza	15	30	Research	Research	NNP
work_sveky7445vfatkdfpzvurqbhza	15	31	Institute	Institute	NNP
work_sveky7445vfatkdfpzvurqbhza	15	32	,	,	,
work_sveky7445vfatkdfpzvurqbhza	15	33	Toronto	Toronto	NNP
work_sveky7445vfatkdfpzvurqbhza	15	34	,	,	,
work_sveky7445vfatkdfpzvurqbhza	15	35	ON	ON	NNP
work_sveky7445vfatkdfpzvurqbhza	15	36	,	,	,
work_sveky7445vfatkdfpzvurqbhza	15	37	Canada	Canada	NNP
work_sveky7445vfatkdfpzvurqbhza	15	38	;	;	:
work_sveky7445vfatkdfpzvurqbhza	15	39	2Institute	2institute	CD
work_sveky7445vfatkdfpzvurqbhza	15	40	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	15	41	Health	Health	NNP
work_sveky7445vfatkdfpzvurqbhza	15	42	Economics	Economics	NNP
work_sveky7445vfatkdfpzvurqbhza	15	43	,	,	,
work_sveky7445vfatkdfpzvurqbhza	15	44	Edmonton	Edmonton	NNP
work_sveky7445vfatkdfpzvurqbhza	15	45	,	,	,
work_sveky7445vfatkdfpzvurqbhza	15	46	AB	AB	NNP
work_sveky7445vfatkdfpzvurqbhza	15	47	,	,	,
work_sveky7445vfatkdfpzvurqbhza	15	48	Canada	Canada	NNP
work_sveky7445vfatkdfpzvurqbhza	15	49	OBJECTIVES	OBJECTIVES	NNP
work_sveky7445vfatkdfpzvurqbhza	15	50	:	:	:
work_sveky7445vfatkdfpzvurqbhza	15	51	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	15	52	Pediatric	Pediatric	NNP
work_sveky7445vfatkdfpzvurqbhza	15	53	Economic	Economic	NNP
work_sveky7445vfatkdfpzvurqbhza	15	54	Database	Database	NNP
work_sveky7445vfatkdfpzvurqbhza	15	55	Evaluation	Evaluation	NNP
work_sveky7445vfatkdfpzvurqbhza	15	56	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	15	57	PEDE	PEDE	NNP
work_sveky7445vfatkdfpzvurqbhza	15	58	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	15	59	Project	Project	NNP
work_sveky7445vfatkdfpzvurqbhza	15	60	features	feature	VBZ
work_sveky7445vfatkdfpzvurqbhza	15	61	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	15	62	database	database	NN
work_sveky7445vfatkdfpzvurqbhza	15	63	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	15	64	787	787	CD
work_sveky7445vfatkdfpzvurqbhza	15	65	pediatric	pediatric	JJ
work_sveky7445vfatkdfpzvurqbhza	15	66	economic	economic	JJ
work_sveky7445vfatkdfpzvurqbhza	15	67	evaluations	evaluation	NNS
work_sveky7445vfatkdfpzvurqbhza	15	68	published	publish	VBN
work_sveky7445vfatkdfpzvurqbhza	15	69	between	between	IN
work_sveky7445vfatkdfpzvurqbhza	15	70	1980	1980	CD
work_sveky7445vfatkdfpzvurqbhza	15	71	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	15	72	1999	1999	CD
work_sveky7445vfatkdfpzvurqbhza	15	73	.	.	.
work_sveky7445vfatkdfpzvurqbhza	16	1	A	a	DT
work_sveky7445vfatkdfpzvurqbhza	16	2	goal	goal	NN
work_sveky7445vfatkdfpzvurqbhza	16	3	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	16	4	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	16	5	PEDE	PEDE	NNP
work_sveky7445vfatkdfpzvurqbhza	16	6	Project	Project	NNP
work_sveky7445vfatkdfpzvurqbhza	16	7	is	be	VBZ
work_sveky7445vfatkdfpzvurqbhza	16	8	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	16	9	appraise	appraise	VB
work_sveky7445vfatkdfpzvurqbhza	16	10	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	16	11	quality	quality	NN
work_sveky7445vfatkdfpzvurqbhza	16	12	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	16	13	pediatric	pediatric	JJ
work_sveky7445vfatkdfpzvurqbhza	16	14	economic	economic	JJ
work_sveky7445vfatkdfpzvurqbhza	16	15	evaluations	evaluation	NNS
work_sveky7445vfatkdfpzvurqbhza	16	16	published	publish	VBN
work_sveky7445vfatkdfpzvurqbhza	16	17	over	over	IN
work_sveky7445vfatkdfpzvurqbhza	16	18	this	this	DT
work_sveky7445vfatkdfpzvurqbhza	16	19	period	period	NN
work_sveky7445vfatkdfpzvurqbhza	16	20	.	.	.
work_sveky7445vfatkdfpzvurqbhza	17	1	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	17	2	objective	objective	NN
work_sveky7445vfatkdfpzvurqbhza	17	3	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	17	4	this	this	DT
work_sveky7445vfatkdfpzvurqbhza	17	5	research	research	NN
work_sveky7445vfatkdfpzvurqbhza	17	6	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	17	7	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	17	8	develop	develop	VB
work_sveky7445vfatkdfpzvurqbhza	17	9	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	17	10	valid	valid	JJ
work_sveky7445vfatkdfpzvurqbhza	17	11	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	17	12	reliable	reliable	JJ
work_sveky7445vfatkdfpzvurqbhza	17	13	quality	quality	NN
work_sveky7445vfatkdfpzvurqbhza	17	14	appraisal	appraisal	NN
work_sveky7445vfatkdfpzvurqbhza	17	15	instrument	instrument	NNP
work_sveky7445vfatkdfpzvurqbhza	17	16	applica-	applica-	NNP
work_sveky7445vfatkdfpzvurqbhza	17	17	ble	ble	NNP
work_sveky7445vfatkdfpzvurqbhza	17	18	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	17	19	economic	economic	JJ
work_sveky7445vfatkdfpzvurqbhza	17	20	evaluations	evaluation	NNS
work_sveky7445vfatkdfpzvurqbhza	17	21	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	17	22	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	17	23	pediatric	pediatric	JJ
work_sveky7445vfatkdfpzvurqbhza	17	24	population	population	NN
work_sveky7445vfatkdfpzvurqbhza	17	25	.	.	.
work_sveky7445vfatkdfpzvurqbhza	18	1	METHODS	METHODS	NNP
work_sveky7445vfatkdfpzvurqbhza	18	2	:	:	:
work_sveky7445vfatkdfpzvurqbhza	18	3	A	a	DT
work_sveky7445vfatkdfpzvurqbhza	18	4	draft	draft	NN
work_sveky7445vfatkdfpzvurqbhza	18	5	instrument	instrument	NN
work_sveky7445vfatkdfpzvurqbhza	18	6	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	18	7	constructed	construct	VBN
work_sveky7445vfatkdfpzvurqbhza	18	8	from	from	IN
work_sveky7445vfatkdfpzvurqbhza	18	9	published	publish	VBN
work_sveky7445vfatkdfpzvurqbhza	18	10	checklists	checklist	NNS
work_sveky7445vfatkdfpzvurqbhza	18	11	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	18	12	questionnaires	questionnaire	NNS
work_sveky7445vfatkdfpzvurqbhza	18	13	.	.	.
work_sveky7445vfatkdfpzvurqbhza	19	1	New	new	JJ
work_sveky7445vfatkdfpzvurqbhza	19	2	questions	question	NNS
work_sveky7445vfatkdfpzvurqbhza	19	3	pertaining	pertain	VBG
work_sveky7445vfatkdfpzvurqbhza	19	4	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	19	5	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	19	6	pediatric	pediatric	JJ
work_sveky7445vfatkdfpzvurqbhza	19	7	population	population	NN
work_sveky7445vfatkdfpzvurqbhza	19	8	were	be	VBD
work_sveky7445vfatkdfpzvurqbhza	19	9	incorporated	incorporate	VBN
work_sveky7445vfatkdfpzvurqbhza	19	10	.	.	.
work_sveky7445vfatkdfpzvurqbhza	20	1	An	an	DT
work_sveky7445vfatkdfpzvurqbhza	20	2	expert	expert	NN
work_sveky7445vfatkdfpzvurqbhza	20	3	panel	panel	NN
work_sveky7445vfatkdfpzvurqbhza	20	4	reviewed	review	VBD
work_sveky7445vfatkdfpzvurqbhza	20	5	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	20	6	draft	draft	NN
work_sveky7445vfatkdfpzvurqbhza	20	7	instrument	instrument	NN
work_sveky7445vfatkdfpzvurqbhza	20	8	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	20	9	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	20	10	proposed	propose	VBN
work_sveky7445vfatkdfpzvurqbhza	20	11	scoring	score	VBG
work_sveky7445vfatkdfpzvurqbhza	20	12	scheme	scheme	NN
work_sveky7445vfatkdfpzvurqbhza	20	13	for	for	IN
work_sveky7445vfatkdfpzvurqbhza	20	14	face	face	NN
work_sveky7445vfatkdfpzvurqbhza	20	15	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	20	16	content	content	NN
work_sveky7445vfatkdfpzvurqbhza	20	17	validity	validity	NN
work_sveky7445vfatkdfpzvurqbhza	20	18	.	.	.
work_sveky7445vfatkdfpzvurqbhza	21	1	A	a	DT
work_sveky7445vfatkdfpzvurqbhza	21	2	revised	revise	VBN
work_sveky7445vfatkdfpzvurqbhza	21	3	version	version	NN
work_sveky7445vfatkdfpzvurqbhza	21	4	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	21	5	pilot	pilot	NN
work_sveky7445vfatkdfpzvurqbhza	21	6	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	21	7	tested	test	VBN
work_sveky7445vfatkdfpzvurqbhza	21	8	by	by	IN
work_sveky7445vfatkdfpzvurqbhza	21	9	three	three	CD
work_sveky7445vfatkdfpzvurqbhza	21	10	independent	independent	JJ
work_sveky7445vfatkdfpzvurqbhza	21	11	appraisers	appraiser	NNS
work_sveky7445vfatkdfpzvurqbhza	21	12	.	.	.
work_sveky7445vfatkdfpzvurqbhza	22	1	After	after	IN
work_sveky7445vfatkdfpzvurqbhza	22	2	addressing	address	VBG
work_sveky7445vfatkdfpzvurqbhza	22	3	discrepancies	discrepancy	NNS
work_sveky7445vfatkdfpzvurqbhza	22	4	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	22	5	scores	score	NNS
work_sveky7445vfatkdfpzvurqbhza	22	6	,	,	,
work_sveky7445vfatkdfpzvurqbhza	22	7	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	22	8	final	final	JJ
work_sveky7445vfatkdfpzvurqbhza	22	9	version	version	NN
work_sveky7445vfatkdfpzvurqbhza	22	10	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	22	11	created	create	VBN
work_sveky7445vfatkdfpzvurqbhza	22	12	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	22	13	subjected	subject	VBN
work_sveky7445vfatkdfpzvurqbhza	22	14	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	22	15	inter	inter	JJ
work_sveky7445vfatkdfpzvurqbhza	22	16	-	-	JJ
work_sveky7445vfatkdfpzvurqbhza	22	17	rater	rater	JJ
work_sveky7445vfatkdfpzvurqbhza	22	18	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	22	19	test	test	NN
work_sveky7445vfatkdfpzvurqbhza	22	20	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	22	21	retest	ret	JJS
work_sveky7445vfatkdfpzvurqbhza	22	22	reliability	reliability	NN
work_sveky7445vfatkdfpzvurqbhza	22	23	assessment	assessment	NN
work_sveky7445vfatkdfpzvurqbhza	22	24	.	.	.
work_sveky7445vfatkdfpzvurqbhza	23	1	RESULTS	RESULTS	NNP
work_sveky7445vfatkdfpzvurqbhza	23	2	:	:	:
work_sveky7445vfatkdfpzvurqbhza	23	3	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	23	4	57	57	CD
work_sveky7445vfatkdfpzvurqbhza	23	5	items	item	NNS
work_sveky7445vfatkdfpzvurqbhza	23	6	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	23	7	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	23	8	final	final	JJ
work_sveky7445vfatkdfpzvurqbhza	23	9	questionnaire	questionnaire	NN
work_sveky7445vfatkdfpzvurqbhza	23	10	were	be	VBD
work_sveky7445vfatkdfpzvurqbhza	23	11	mapped	map	VBN
work_sveky7445vfatkdfpzvurqbhza	23	12	onto	onto	IN
work_sveky7445vfatkdfpzvurqbhza	23	13	fourteen	fourteen	CD
work_sveky7445vfatkdfpzvurqbhza	23	14	domains	domain	NNS
work_sveky7445vfatkdfpzvurqbhza	23	15	:	:	:
work_sveky7445vfatkdfpzvurqbhza	23	16	economic	economic	JJ
work_sveky7445vfatkdfpzvurqbhza	23	17	evaluation	evaluation	NN
work_sveky7445vfatkdfpzvurqbhza	23	18	,	,	,
work_sveky7445vfatkdfpzvurqbhza	23	19	comparators	comparator	NNS
work_sveky7445vfatkdfpzvurqbhza	23	20	,	,	,
work_sveky7445vfatkdfpzvurqbhza	23	21	target	target	NN
work_sveky7445vfatkdfpzvurqbhza	23	22	population	population	NN
work_sveky7445vfatkdfpzvurqbhza	23	23	,	,	,
work_sveky7445vfatkdfpzvurqbhza	23	24	time	time	NN
work_sveky7445vfatkdfpzvurqbhza	23	25	horizon	horizon	NN
work_sveky7445vfatkdfpzvurqbhza	23	26	,	,	,
work_sveky7445vfatkdfpzvurqbhza	23	27	perspec-	perspec-	NNP
work_sveky7445vfatkdfpzvurqbhza	23	28	tive	tive	NNP
work_sveky7445vfatkdfpzvurqbhza	23	29	,	,	,
work_sveky7445vfatkdfpzvurqbhza	23	30	costs	cost	NNS
work_sveky7445vfatkdfpzvurqbhza	23	31	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	23	32	resource	resource	NN
work_sveky7445vfatkdfpzvurqbhza	23	33	use	use	NN
work_sveky7445vfatkdfpzvurqbhza	23	34	,	,	,
work_sveky7445vfatkdfpzvurqbhza	23	35	outcomes	outcome	NNS
work_sveky7445vfatkdfpzvurqbhza	23	36	,	,	,
work_sveky7445vfatkdfpzvurqbhza	23	37	quality	quality	NN
work_sveky7445vfatkdfpzvurqbhza	23	38	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	23	39	life	life	NN
work_sveky7445vfatkdfpzvurqbhza	23	40	,	,	,
work_sveky7445vfatkdfpzvurqbhza	23	41	analysis	analysis	NN
work_sveky7445vfatkdfpzvurqbhza	23	42	,	,	,
work_sveky7445vfatkdfpzvurqbhza	23	43	discounting	discount	VBG
work_sveky7445vfatkdfpzvurqbhza	23	44	,	,	,
work_sveky7445vfatkdfpzvurqbhza	23	45	incremental	incremental	JJ
work_sveky7445vfatkdfpzvurqbhza	23	46	analysis	analysis	NN
work_sveky7445vfatkdfpzvurqbhza	23	47	,	,	,
work_sveky7445vfatkdfpzvurqbhza	23	48	sensitivity	sensitivity	NN
work_sveky7445vfatkdfpzvurqbhza	23	49	analysis	analysis	NN
work_sveky7445vfatkdfpzvurqbhza	23	50	,	,	,
work_sveky7445vfatkdfpzvurqbhza	23	51	conflict	conflict	NN
work_sveky7445vfatkdfpzvurqbhza	23	52	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	23	53	interest	interest	NN
work_sveky7445vfatkdfpzvurqbhza	23	54	,	,	,
work_sveky7445vfatkdfpzvurqbhza	23	55	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	23	56	conclusions	conclusion	NNS
work_sveky7445vfatkdfpzvurqbhza	23	57	.	.	.
work_sveky7445vfatkdfpzvurqbhza	24	1	Among	among	IN
work_sveky7445vfatkdfpzvurqbhza	24	2	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	24	3	57	57	CD
work_sveky7445vfatkdfpzvurqbhza	24	4	items	item	NNS
work_sveky7445vfatkdfpzvurqbhza	24	5	,	,	,
work_sveky7445vfatkdfpzvurqbhza	24	6	46	46	CD
work_sveky7445vfatkdfpzvurqbhza	24	7	have	have	VBP
work_sveky7445vfatkdfpzvurqbhza	24	8	response	response	NN
work_sveky7445vfatkdfpzvurqbhza	24	9	options	option	NNS
work_sveky7445vfatkdfpzvurqbhza	24	10	that	that	WDT
work_sveky7445vfatkdfpzvurqbhza	24	11	are	be	VBP
work_sveky7445vfatkdfpzvurqbhza	24	12	scored	score	VBN
work_sveky7445vfatkdfpzvurqbhza	24	13	from	from	IN
work_sveky7445vfatkdfpzvurqbhza	24	14	0	0	CD
work_sveky7445vfatkdfpzvurqbhza	24	15	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	24	16	1	1	CD
work_sveky7445vfatkdfpzvurqbhza	24	17	.	.	.
work_sveky7445vfatkdfpzvurqbhza	25	1	Inter	inter	JJ
work_sveky7445vfatkdfpzvurqbhza	25	2	-	-	JJ
work_sveky7445vfatkdfpzvurqbhza	25	3	rater	rater	JJ
work_sveky7445vfatkdfpzvurqbhza	25	4	reliability	reliability	NN
work_sveky7445vfatkdfpzvurqbhza	25	5	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	25	6	0.75	0.75	CD
work_sveky7445vfatkdfpzvurqbhza	25	7	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	25	8	95	95	CD
work_sveky7445vfatkdfpzvurqbhza	25	9	%	%	NN
work_sveky7445vfatkdfpzvurqbhza	25	10	CI	CI	NNP
work_sveky7445vfatkdfpzvurqbhza	25	11	0.66–0.81	0.66–0.81	NNP
work_sveky7445vfatkdfpzvurqbhza	25	12	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	25	13	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	25	14	test	test	NN
work_sveky7445vfatkdfpzvurqbhza	25	15	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	25	16	retest	ret	JJS
work_sveky7445vfatkdfpzvurqbhza	25	17	reliability	reliability	NN
work_sveky7445vfatkdfpzvurqbhza	25	18	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	25	19	0.92	0.92	CD
work_sveky7445vfatkdfpzvurqbhza	25	20	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	25	21	95	95	CD
work_sveky7445vfatkdfpzvurqbhza	25	22	%	%	NN
work_sveky7445vfatkdfpzvurqbhza	25	23	CI	CI	NNP
work_sveky7445vfatkdfpzvurqbhza	25	24	0.71–0.98	0.71–0.98	NNP
work_sveky7445vfatkdfpzvurqbhza	25	25	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	25	26	.	.	.
work_sveky7445vfatkdfpzvurqbhza	26	1	CONCLUSIONS	conclusion	NNS
work_sveky7445vfatkdfpzvurqbhza	26	2	:	:	:
work_sveky7445vfatkdfpzvurqbhza	26	3	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	26	4	Pediatric	Pediatric	NNP
work_sveky7445vfatkdfpzvurqbhza	26	5	Quality	Quality	NNP
work_sveky7445vfatkdfpzvurqbhza	26	6	Appraisal	Appraisal	NNP
work_sveky7445vfatkdfpzvurqbhza	26	7	Ques-	Ques-	NNP
work_sveky7445vfatkdfpzvurqbhza	26	8	tionnaire	tionnaire	NN
work_sveky7445vfatkdfpzvurqbhza	26	9	is	be	VBZ
work_sveky7445vfatkdfpzvurqbhza	26	10	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	26	11	comprehensive	comprehensive	JJ
work_sveky7445vfatkdfpzvurqbhza	26	12	instrument	instrument	NN
work_sveky7445vfatkdfpzvurqbhza	26	13	demonstrating	demonstrate	VBG
work_sveky7445vfatkdfpzvurqbhza	26	14	face	face	NN
work_sveky7445vfatkdfpzvurqbhza	26	15	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	26	16	content	content	NN
work_sveky7445vfatkdfpzvurqbhza	26	17	validity	validity	NN
work_sveky7445vfatkdfpzvurqbhza	26	18	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	26	19	very	very	RB
work_sveky7445vfatkdfpzvurqbhza	26	20	good	good	JJ
work_sveky7445vfatkdfpzvurqbhza	26	21	reliability	reliability	NN
work_sveky7445vfatkdfpzvurqbhza	26	22	for	for	IN
work_sveky7445vfatkdfpzvurqbhza	26	23	application	application	NN
work_sveky7445vfatkdfpzvurqbhza	26	24	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	26	25	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	26	26	appraisal	appraisal	NN
work_sveky7445vfatkdfpzvurqbhza	26	27	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	26	28	pediatric	pediatric	JJ
work_sveky7445vfatkdfpzvurqbhza	26	29	economic	economic	JJ
work_sveky7445vfatkdfpzvurqbhza	26	30	evalu-	evalu-	NNS
work_sveky7445vfatkdfpzvurqbhza	26	31	ations	ation	NNS
work_sveky7445vfatkdfpzvurqbhza	26	32	.	.	.
work_sveky7445vfatkdfpzvurqbhza	27	1	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	27	2	instrument	instrument	NN
work_sveky7445vfatkdfpzvurqbhza	27	3	is	be	VBZ
work_sveky7445vfatkdfpzvurqbhza	27	4	currently	currently	RB
work_sveky7445vfatkdfpzvurqbhza	27	5	being	be	VBG
work_sveky7445vfatkdfpzvurqbhza	27	6	used	use	VBN
work_sveky7445vfatkdfpzvurqbhza	27	7	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	27	8	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	27	9	quality	quality	NN
work_sveky7445vfatkdfpzvurqbhza	27	10	appraisal	appraisal	NN
work_sveky7445vfatkdfpzvurqbhza	27	11	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	27	12	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	27	13	random	random	JJ
work_sveky7445vfatkdfpzvurqbhza	27	14	sample	sample	NN
work_sveky7445vfatkdfpzvurqbhza	27	15	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	27	16	150	150	CD
work_sveky7445vfatkdfpzvurqbhza	27	17	publications	publication	NNS
work_sveky7445vfatkdfpzvurqbhza	27	18	from	from	IN
work_sveky7445vfatkdfpzvurqbhza	27	19	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	27	20	PEDE	PEDE	NNP
work_sveky7445vfatkdfpzvurqbhza	27	21	database	database	NN
work_sveky7445vfatkdfpzvurqbhza	27	22	.	.	.
work_sveky7445vfatkdfpzvurqbhza	28	1	HEALTH	health	NN
work_sveky7445vfatkdfpzvurqbhza	28	2	POLICY	policy	NN
work_sveky7445vfatkdfpzvurqbhza	28	3	—	—	:
work_sveky7445vfatkdfpzvurqbhza	28	4	CONSUMER	consumer	NN
work_sveky7445vfatkdfpzvurqbhza	28	5	ADVERTISING	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	28	6	ISSUES	issues	NN
work_sveky7445vfatkdfpzvurqbhza	28	7	HP5	hp5	VBP
work_sveky7445vfatkdfpzvurqbhza	28	8	THE	the	DT
work_sveky7445vfatkdfpzvurqbhza	28	9	RELATIONSHIP	relationship	NN
work_sveky7445vfatkdfpzvurqbhza	28	10	OF	of	IN
work_sveky7445vfatkdfpzvurqbhza	28	11	DIRECT	direct	NN
work_sveky7445vfatkdfpzvurqbhza	28	12	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	28	13	TO	to	IN
work_sveky7445vfatkdfpzvurqbhza	28	14	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	28	15	CONSUMER	consumer	NN
work_sveky7445vfatkdfpzvurqbhza	28	16	ADVERTISING	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	28	17	AND	and	CC
work_sveky7445vfatkdfpzvurqbhza	28	18	CLINICIAN	clinician	NN
work_sveky7445vfatkdfpzvurqbhza	28	19	BEHAVIORAL	BEHAVIORAL	NNS
work_sveky7445vfatkdfpzvurqbhza	28	20	INTENTIONS	intentions	NN
work_sveky7445vfatkdfpzvurqbhza	28	21	Zachry	zachry	NN
work_sveky7445vfatkdfpzvurqbhza	28	22	III	iii	CD
work_sveky7445vfatkdfpzvurqbhza	28	23	WM	WM	NNP
work_sveky7445vfatkdfpzvurqbhza	28	24	,	,	,
work_sveky7445vfatkdfpzvurqbhza	28	25	Jackson	Jackson	NNP
work_sveky7445vfatkdfpzvurqbhza	28	26	TR	TR	NNP
work_sveky7445vfatkdfpzvurqbhza	28	27	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	28	28	University	University	NNP
work_sveky7445vfatkdfpzvurqbhza	28	29	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	28	30	Arizona	Arizona	NNP
work_sveky7445vfatkdfpzvurqbhza	28	31	,	,	,
work_sveky7445vfatkdfpzvurqbhza	28	32	Tucson	Tucson	NNP
work_sveky7445vfatkdfpzvurqbhza	28	33	,	,	,
work_sveky7445vfatkdfpzvurqbhza	28	34	AZ	AZ	NNP
work_sveky7445vfatkdfpzvurqbhza	28	35	,	,	,
work_sveky7445vfatkdfpzvurqbhza	28	36	USA	USA	NNP
work_sveky7445vfatkdfpzvurqbhza	28	37	OBJECTIVE	OBJECTIVE	NNP
work_sveky7445vfatkdfpzvurqbhza	28	38	:	:	:
work_sveky7445vfatkdfpzvurqbhza	28	39	To	to	TO
work_sveky7445vfatkdfpzvurqbhza	28	40	examine	examine	VB
work_sveky7445vfatkdfpzvurqbhza	28	41	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	28	42	relationship	relationship	NN
work_sveky7445vfatkdfpzvurqbhza	28	43	between	between	IN
work_sveky7445vfatkdfpzvurqbhza	28	44	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	28	45	exposure	exposure	NN
work_sveky7445vfatkdfpzvurqbhza	28	46	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	28	47	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	28	48	patient	patient	NN
work_sveky7445vfatkdfpzvurqbhza	28	49	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	28	50	direct	direct	VB
work_sveky7445vfatkdfpzvurqbhza	28	51	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	28	52	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	28	53	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	28	54	consumer	consumer	NN
work_sveky7445vfatkdfpzvurqbhza	28	55	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	28	56	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	28	57	DTCA	DTCA	NNP
work_sveky7445vfatkdfpzvurqbhza	28	58	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	28	59	,	,	,
work_sveky7445vfatkdfpzvurqbhza	28	60	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	28	61	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	28	62	likelihood	likelihood	NN
work_sveky7445vfatkdfpzvurqbhza	28	63	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	28	64	clinician	clinician	JJ
work_sveky7445vfatkdfpzvurqbhza	28	65	behavioral	behavioral	JJ
work_sveky7445vfatkdfpzvurqbhza	28	66	inten-	inten-	NN
work_sveky7445vfatkdfpzvurqbhza	28	67	tions	tion	NNS
work_sveky7445vfatkdfpzvurqbhza	28	68	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	28	69	provide	provide	VB
work_sveky7445vfatkdfpzvurqbhza	28	70	information	information	NN
work_sveky7445vfatkdfpzvurqbhza	28	71	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	28	72	medications	medication	NNS
work_sveky7445vfatkdfpzvurqbhza	28	73	.	.	.
work_sveky7445vfatkdfpzvurqbhza	29	1	METHODS	METHODS	NNP
work_sveky7445vfatkdfpzvurqbhza	29	2	:	:	:
work_sveky7445vfatkdfpzvurqbhza	29	3	A	a	DT
work_sveky7445vfatkdfpzvurqbhza	29	4	randomized	randomized	JJ
work_sveky7445vfatkdfpzvurqbhza	29	5	mail	mail	NN
work_sveky7445vfatkdfpzvurqbhza	29	6	survey	survey	NN
work_sveky7445vfatkdfpzvurqbhza	29	7	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	29	8	Arizona	Arizona	NNP
work_sveky7445vfatkdfpzvurqbhza	29	9	primary	primary	JJ
work_sveky7445vfatkdfpzvurqbhza	29	10	care	care	NN
work_sveky7445vfatkdfpzvurqbhza	29	11	physicians	physician	NNS
work_sveky7445vfatkdfpzvurqbhza	29	12	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	29	13	n	n	NNP
work_sveky7445vfatkdfpzvurqbhza	29	14	=	=	SYM
work_sveky7445vfatkdfpzvurqbhza	29	15	1080	1080	CD
work_sveky7445vfatkdfpzvurqbhza	29	16	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	29	17	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	29	18	physician	physician	NN
work_sveky7445vfatkdfpzvurqbhza	29	19	assistants	assistant	NNS
work_sveky7445vfatkdfpzvurqbhza	29	20	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	29	21	n	n	NNP
work_sveky7445vfatkdfpzvurqbhza	29	22	=	=	SYM
work_sveky7445vfatkdfpzvurqbhza	29	23	704	704	CD
work_sveky7445vfatkdfpzvurqbhza	29	24	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	29	25	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	29	26	conducted	conduct	VBN
work_sveky7445vfatkdfpzvurqbhza	29	27	.	.	.
work_sveky7445vfatkdfpzvurqbhza	30	1	Questionnaires	questionnaire	NNS
work_sveky7445vfatkdfpzvurqbhza	30	2	were	be	VBD
work_sveky7445vfatkdfpzvurqbhza	30	3	created	create	VBN
work_sveky7445vfatkdfpzvurqbhza	30	4	with	with	IN
work_sveky7445vfatkdfpzvurqbhza	30	5	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	30	6	hypothetical	hypothetical	JJ
work_sveky7445vfatkdfpzvurqbhza	30	7	patient	patient	NN
work_sveky7445vfatkdfpzvurqbhza	30	8	scenario	scenario	NN
work_sveky7445vfatkdfpzvurqbhza	30	9	varying	vary	VBG
work_sveky7445vfatkdfpzvurqbhza	30	10	according	accord	VBG
work_sveky7445vfatkdfpzvurqbhza	30	11	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	30	12	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	30	13	informational	informational	JJ
work_sveky7445vfatkdfpzvurqbhza	30	14	exposure	exposure	NN
work_sveky7445vfatkdfpzvurqbhza	30	15	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	30	16	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	30	17	patient	patient	NN
work_sveky7445vfatkdfpzvurqbhza	30	18	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	30	19	2	2	CD
work_sveky7445vfatkdfpzvurqbhza	30	20	levels	level	NNS
work_sveky7445vfatkdfpzvurqbhza	30	21	:	:	:
work_sveky7445vfatkdfpzvurqbhza	30	22	DTCA	dtca	NN
work_sveky7445vfatkdfpzvurqbhza	30	23	or	or	CC
work_sveky7445vfatkdfpzvurqbhza	30	24	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	30	25	reference	reference	NN
work_sveky7445vfatkdfpzvurqbhza	30	26	book	book	NN
work_sveky7445vfatkdfpzvurqbhza	30	27	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	30	28	.	.	.
work_sveky7445vfatkdfpzvurqbhza	31	1	All	all	DT
work_sveky7445vfatkdfpzvurqbhza	31	2	other	other	JJ
work_sveky7445vfatkdfpzvurqbhza	31	3	wording	wording	NN
work_sveky7445vfatkdfpzvurqbhza	31	4	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	31	5	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	31	6	hypothetical	hypothetical	JJ
work_sveky7445vfatkdfpzvurqbhza	31	7	scenarios	scenario	NNS
work_sveky7445vfatkdfpzvurqbhza	31	8	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	31	9	controlled	control	VBN
work_sveky7445vfatkdfpzvurqbhza	31	10	.	.	.
work_sveky7445vfatkdfpzvurqbhza	32	1	Clinicians	clinician	NNS
work_sveky7445vfatkdfpzvurqbhza	32	2	were	be	VBD
work_sveky7445vfatkdfpzvurqbhza	32	3	randomly	randomly	RB
work_sveky7445vfatkdfpzvurqbhza	32	4	assigned	assign	VBN
work_sveky7445vfatkdfpzvurqbhza	32	5	one	one	CD
work_sveky7445vfatkdfpzvurqbhza	32	6	form	form	NN
work_sveky7445vfatkdfpzvurqbhza	32	7	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	32	8	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	32	9	questionnaire	questionnaire	NN
work_sveky7445vfatkdfpzvurqbhza	32	10	.	.	.
work_sveky7445vfatkdfpzvurqbhza	33	1	Each	each	DT
work_sveky7445vfatkdfpzvurqbhza	33	2	form	form	NN
work_sveky7445vfatkdfpzvurqbhza	33	3	solicited	solicit	VBD
work_sveky7445vfatkdfpzvurqbhza	33	4	responses	response	NNS
work_sveky7445vfatkdfpzvurqbhza	33	5	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	33	6	questions	question	NNS
work_sveky7445vfatkdfpzvurqbhza	33	7	related	relate	VBN
work_sveky7445vfatkdfpzvurqbhza	33	8	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	33	9	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	33	10	likelihood	likelihood	NN
work_sveky7445vfatkdfpzvurqbhza	33	11	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	33	12	respondent	respondent	JJ
work_sveky7445vfatkdfpzvurqbhza	33	13	behavioral	behavioral	JJ
work_sveky7445vfatkdfpzvurqbhza	33	14	intentions	intention	NNS
work_sveky7445vfatkdfpzvurqbhza	33	15	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	33	16	6-point	6-point	CD
work_sveky7445vfatkdfpzvurqbhza	33	17	scale	scale	NN
work_sveky7445vfatkdfpzvurqbhza	33	18	,	,	,
work_sveky7445vfatkdfpzvurqbhza	33	19	6	6	CD
work_sveky7445vfatkdfpzvurqbhza	33	20	=	=	SYM
work_sveky7445vfatkdfpzvurqbhza	33	21	very	very	RB
work_sveky7445vfatkdfpzvurqbhza	33	22	likely	likely	JJ
work_sveky7445vfatkdfpzvurqbhza	33	23	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	33	24	1	1	CD
work_sveky7445vfatkdfpzvurqbhza	33	25	=	=	SYM
work_sveky7445vfatkdfpzvurqbhza	33	26	very	very	RB
work_sveky7445vfatkdfpzvurqbhza	33	27	unlikely	unlikely	JJ
work_sveky7445vfatkdfpzvurqbhza	33	28	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	33	29	when	when	WRB
work_sveky7445vfatkdfpzvurqbhza	33	30	faced	face	VBN
work_sveky7445vfatkdfpzvurqbhza	33	31	with	with	IN
work_sveky7445vfatkdfpzvurqbhza	33	32	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	33	33	hypothetical	hypothetical	JJ
work_sveky7445vfatkdfpzvurqbhza	33	34	patient	patient	NN
work_sveky7445vfatkdfpzvurqbhza	33	35	scenario	scenario	NN
work_sveky7445vfatkdfpzvurqbhza	33	36	.	.	.
work_sveky7445vfatkdfpzvurqbhza	34	1	RESULTS	RESULTS	NNP
work_sveky7445vfatkdfpzvurqbhza	34	2	:	:	:
work_sveky7445vfatkdfpzvurqbhza	34	3	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	34	4	response	response	NN
work_sveky7445vfatkdfpzvurqbhza	34	5	rate	rate	NN
work_sveky7445vfatkdfpzvurqbhza	34	6	for	for	IN
work_sveky7445vfatkdfpzvurqbhza	34	7	useable	useable	JJ
work_sveky7445vfatkdfpzvurqbhza	34	8	questionnaires	questionnaire	NNS
work_sveky7445vfatkdfpzvurqbhza	34	9	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	34	10	44	44	CD
work_sveky7445vfatkdfpzvurqbhza	34	11	%	%	NN
work_sveky7445vfatkdfpzvurqbhza	34	12	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	34	13	40.5	40.5	CD
work_sveky7445vfatkdfpzvurqbhza	34	14	%	%	NN
work_sveky7445vfatkdfpzvurqbhza	34	15	physicians	physician	NNS
work_sveky7445vfatkdfpzvurqbhza	34	16	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	34	17	49.3	49.3	CD
work_sveky7445vfatkdfpzvurqbhza	34	18	%	%	NN
work_sveky7445vfatkdfpzvurqbhza	34	19	physician	physician	NN
work_sveky7445vfatkdfpzvurqbhza	34	20	assis-	assis-	VBG
work_sveky7445vfatkdfpzvurqbhza	34	21	tants	tant	NNS
work_sveky7445vfatkdfpzvurqbhza	34	22	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	34	23	.	.	.
work_sveky7445vfatkdfpzvurqbhza	35	1	No	no	DT
work_sveky7445vfatkdfpzvurqbhza	35	2	overall	overall	JJ
work_sveky7445vfatkdfpzvurqbhza	35	3	statistically	statistically	RB
work_sveky7445vfatkdfpzvurqbhza	35	4	significant	significant	JJ
work_sveky7445vfatkdfpzvurqbhza	35	5	differences	difference	NNS
work_sveky7445vfatkdfpzvurqbhza	35	6	were	be	VBD
work_sveky7445vfatkdfpzvurqbhza	35	7	found	find	VBN
work_sveky7445vfatkdfpzvurqbhza	35	8	between	between	IN
work_sveky7445vfatkdfpzvurqbhza	35	9	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	35	10	early	early	JJ
work_sveky7445vfatkdfpzvurqbhza	35	11	responders	responder	NNS
work_sveky7445vfatkdfpzvurqbhza	35	12	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	35	13	late	late	JJ
work_sveky7445vfatkdfpzvurqbhza	35	14	responders	responder	NNS
work_sveky7445vfatkdfpzvurqbhza	35	15	.	.	.
work_sveky7445vfatkdfpzvurqbhza	36	1	Also	also	RB
work_sveky7445vfatkdfpzvurqbhza	36	2	,	,	,
work_sveky7445vfatkdfpzvurqbhza	36	3	no	no	DT
work_sveky7445vfatkdfpzvurqbhza	36	4	statistically	statistically	RB
work_sveky7445vfatkdfpzvurqbhza	36	5	significant	significant	JJ
work_sveky7445vfatkdfpzvurqbhza	36	6	differences	difference	NNS
work_sveky7445vfatkdfpzvurqbhza	36	7	were	be	VBD
work_sveky7445vfatkdfpzvurqbhza	36	8	found	find	VBN
work_sveky7445vfatkdfpzvurqbhza	36	9	between	between	IN
work_sveky7445vfatkdfpzvurqbhza	36	10	responders	responder	NNS
work_sveky7445vfatkdfpzvurqbhza	36	11	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	36	12	non	non	NNS
work_sveky7445vfatkdfpzvurqbhza	36	13	-	-	NNS
work_sveky7445vfatkdfpzvurqbhza	36	14	responders	responder	NNS
work_sveky7445vfatkdfpzvurqbhza	36	15	based	base	VBN
work_sveky7445vfatkdfpzvurqbhza	36	16	on	on	IN
work_sveky7445vfatkdfpzvurqbhza	36	17	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	36	18	metropolitan	metropolitan	JJ
work_sveky7445vfatkdfpzvurqbhza	36	19	designations	designation	NNS
work_sveky7445vfatkdfpzvurqbhza	36	20	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	36	21	their	-PRON-	PRP$
work_sveky7445vfatkdfpzvurqbhza	36	22	practice	practice	NN
work_sveky7445vfatkdfpzvurqbhza	36	23	settings	setting	NNS
work_sveky7445vfatkdfpzvurqbhza	36	24	.	.	.
work_sveky7445vfatkdfpzvurqbhza	37	1	Relative	relative	JJ
work_sveky7445vfatkdfpzvurqbhza	37	2	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	37	3	clinicians	clinician	NNS
work_sveky7445vfatkdfpzvurqbhza	37	4	who	who	WP
work_sveky7445vfatkdfpzvurqbhza	37	5	received	receive	VBD
work_sveky7445vfatkdfpzvurqbhza	37	6	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	37	7	“	"	``
work_sveky7445vfatkdfpzvurqbhza	37	8	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	37	9	reference	reference	NN
work_sveky7445vfatkdfpzvurqbhza	37	10	book	book	NN
work_sveky7445vfatkdfpzvurqbhza	37	11	”	"	''
work_sveky7445vfatkdfpzvurqbhza	37	12	patient	patient	NN
work_sveky7445vfatkdfpzvurqbhza	37	13	scenario	scenario	NN
work_sveky7445vfatkdfpzvurqbhza	37	14	,	,	,
work_sveky7445vfatkdfpzvurqbhza	37	15	clinicians	clinicians	NNPS
work_sveky7445vfatkdfpzvurqbhza	37	16	who	who	WP
work_sveky7445vfatkdfpzvurqbhza	37	17	received	receive	VBD
work_sveky7445vfatkdfpzvurqbhza	37	18	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	37	19	DTCA	DTCA	NNP
work_sveky7445vfatkdfpzvurqbhza	37	20	patient	patient	NN
work_sveky7445vfatkdfpzvurqbhza	37	21	scenario	scenario	NN
work_sveky7445vfatkdfpzvurqbhza	37	22	were	be	VBD
work_sveky7445vfatkdfpzvurqbhza	37	23	:	:	:
work_sveky7445vfatkdfpzvurqbhza	37	24	more	more	RBR
work_sveky7445vfatkdfpzvurqbhza	37	25	likely	likely	JJ
work_sveky7445vfatkdfpzvurqbhza	37	26	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	37	27	become	become	VB
work_sveky7445vfatkdfpzvurqbhza	37	28	annoyed	annoyed	JJ
work_sveky7445vfatkdfpzvurqbhza	37	29	with	with	IN
work_sveky7445vfatkdfpzvurqbhza	37	30	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	37	31	patient	patient	NN
work_sveky7445vfatkdfpzvurqbhza	37	32	for	for	IN
work_sveky7445vfatkdfpzvurqbhza	37	33	asking	ask	VBG
work_sveky7445vfatkdfpzvurqbhza	37	34	for	for	IN
work_sveky7445vfatkdfpzvurqbhza	37	35	more	more	JJR
work_sveky7445vfatkdfpzvurqbhza	37	36	information	information	NN
work_sveky7445vfatkdfpzvurqbhza	37	37	about	about	IN
work_sveky7445vfatkdfpzvurqbhza	37	38	medications	medication	NNS
work_sveky7445vfatkdfpzvurqbhza	37	39	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	37	40	p	p	NN
work_sveky7445vfatkdfpzvurqbhza	37	41	=	=	SYM
work_sveky7445vfatkdfpzvurqbhza	37	42	0.003	0.003	CD
work_sveky7445vfatkdfpzvurqbhza	37	43	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	37	44	;	;	:
work_sveky7445vfatkdfpzvurqbhza	37	45	less	less	RBR
work_sveky7445vfatkdfpzvurqbhza	37	46	likely	likely	JJ
work_sveky7445vfatkdfpzvurqbhza	37	47	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	37	48	answer	answer	VB
work_sveky7445vfatkdfpzvurqbhza	37	49	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	37	50	patient	patient	NN
work_sveky7445vfatkdfpzvurqbhza	37	51	’s	’s	POS
work_sveky7445vfatkdfpzvurqbhza	37	52	questions	question	NNS
work_sveky7445vfatkdfpzvurqbhza	37	53	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	37	54	p	p	NN
work_sveky7445vfatkdfpzvurqbhza	37	55	=	=	SYM
work_sveky7445vfatkdfpzvurqbhza	37	56	0.028	0.028	CD
work_sveky7445vfatkdfpzvurqbhza	37	57	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	37	58	or	or	CC
work_sveky7445vfatkdfpzvurqbhza	37	59	provide	provide	VB
work_sveky7445vfatkdfpzvurqbhza	37	60	additional	additional	JJ
work_sveky7445vfatkdfpzvurqbhza	37	61	written	write	VBN
work_sveky7445vfatkdfpzvurqbhza	37	62	information	information	NN
work_sveky7445vfatkdfpzvurqbhza	37	63	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	37	64	p	p	NN
work_sveky7445vfatkdfpzvurqbhza	37	65	=	=	SYM
work_sveky7445vfatkdfpzvurqbhza	37	66	0.007	0.007	CD
work_sveky7445vfatkdfpzvurqbhza	37	67	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	37	68	;	;	:
work_sveky7445vfatkdfpzvurqbhza	37	69	more	more	RBR
work_sveky7445vfatkdfpzvurqbhza	37	70	likely	likely	JJ
work_sveky7445vfatkdfpzvurqbhza	37	71	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	37	72	attempt	attempt	VB
work_sveky7445vfatkdfpzvurqbhza	37	73	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	37	74	change	change	VB
work_sveky7445vfatkdfpzvurqbhza	37	75	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	37	76	subject	subject	NN
work_sveky7445vfatkdfpzvurqbhza	37	77	rather	rather	RB
work_sveky7445vfatkdfpzvurqbhza	37	78	than	than	IN
work_sveky7445vfatkdfpzvurqbhza	37	79	discuss	discuss	VB
work_sveky7445vfatkdfpzvurqbhza	37	80	an	an	DT
work_sveky7445vfatkdfpzvurqbhza	37	81	advertised	advertise	VBN
work_sveky7445vfatkdfpzvurqbhza	37	82	133Abstracts	133abstract	NNS
work_sveky7445vfatkdfpzvurqbhza	37	83	medication	medication	NN
work_sveky7445vfatkdfpzvurqbhza	37	84	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	37	85	p	p	NN
work_sveky7445vfatkdfpzvurqbhza	37	86	=	=	SYM
work_sveky7445vfatkdfpzvurqbhza	37	87	0.017	0.017	CD
work_sveky7445vfatkdfpzvurqbhza	37	88	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	37	89	;	;	:
work_sveky7445vfatkdfpzvurqbhza	37	90	more	more	RBR
work_sveky7445vfatkdfpzvurqbhza	37	91	likely	likely	JJ
work_sveky7445vfatkdfpzvurqbhza	37	92	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	37	93	become	become	VB
work_sveky7445vfatkdfpzvurqbhza	37	94	frustrated	frustrated	JJ
work_sveky7445vfatkdfpzvurqbhza	37	95	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	37	96	p	p	NN
work_sveky7445vfatkdfpzvurqbhza	37	97	=	=	SYM
work_sveky7445vfatkdfpzvurqbhza	37	98	0.003	0.003	CD
work_sveky7445vfatkdfpzvurqbhza	37	99	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	37	100	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	37	101	annoyed	annoy	VBN
work_sveky7445vfatkdfpzvurqbhza	37	102	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	37	103	p	p	NNP
work_sveky7445vfatkdfpzvurqbhza	37	104	<	<	XX
work_sveky7445vfatkdfpzvurqbhza	37	105	0.001	0.001	CD
work_sveky7445vfatkdfpzvurqbhza	37	106	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	37	107	with	with	IN
work_sveky7445vfatkdfpzvurqbhza	37	108	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	37	109	patient	patient	NN
work_sveky7445vfatkdfpzvurqbhza	37	110	for	for	IN
work_sveky7445vfatkdfpzvurqbhza	37	111	asking	ask	VBG
work_sveky7445vfatkdfpzvurqbhza	37	112	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	37	113	try	try	VB
work_sveky7445vfatkdfpzvurqbhza	37	114	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	37	115	medication	medication	NN
work_sveky7445vfatkdfpzvurqbhza	37	116	;	;	:
work_sveky7445vfatkdfpzvurqbhza	37	117	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	37	118	less	less	RBR
work_sveky7445vfatkdfpzvurqbhza	37	119	likely	likely	JJ
work_sveky7445vfatkdfpzvurqbhza	37	120	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	37	121	provide	provide	VB
work_sveky7445vfatkdfpzvurqbhza	37	122	samples	sample	NNS
work_sveky7445vfatkdfpzvurqbhza	37	123	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	37	124	p	p	NN
work_sveky7445vfatkdfpzvurqbhza	37	125	=	=	SYM
work_sveky7445vfatkdfpzvurqbhza	37	126	0.001	0.001	CD
work_sveky7445vfatkdfpzvurqbhza	37	127	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	37	128	or	or	CC
work_sveky7445vfatkdfpzvurqbhza	37	129	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	37	130	prescription	prescription	NN
work_sveky7445vfatkdfpzvurqbhza	37	131	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	37	132	p	p	NN
work_sveky7445vfatkdfpzvurqbhza	37	133	<	<	XX
work_sveky7445vfatkdfpzvurqbhza	37	134	0.001	0.001	CD
work_sveky7445vfatkdfpzvurqbhza	37	135	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	37	136	for	for	IN
work_sveky7445vfatkdfpzvurqbhza	37	137	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	37	138	medication	medication	NN
work_sveky7445vfatkdfpzvurqbhza	37	139	.	.	.
work_sveky7445vfatkdfpzvurqbhza	38	1	CONCLUSION	conclusion	NN
work_sveky7445vfatkdfpzvurqbhza	38	2	:	:	:
work_sveky7445vfatkdfpzvurqbhza	38	3	Clinicians	clinician	NNS
work_sveky7445vfatkdfpzvurqbhza	38	4	are	be	VBP
work_sveky7445vfatkdfpzvurqbhza	38	5	amenable	amenable	JJ
work_sveky7445vfatkdfpzvurqbhza	38	6	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	38	7	patients	patient	NNS
work_sveky7445vfatkdfpzvurqbhza	38	8	asking	ask	VBG
work_sveky7445vfatkdfpzvurqbhza	38	9	for	for	IN
work_sveky7445vfatkdfpzvurqbhza	38	10	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	38	11	information	information	NN
work_sveky7445vfatkdfpzvurqbhza	38	12	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	38	13	medications	medication	NNS
work_sveky7445vfatkdfpzvurqbhza	38	14	,	,	,
work_sveky7445vfatkdfpzvurqbhza	38	15	but	but	CC
work_sveky7445vfatkdfpzvurqbhza	38	16	their	-PRON-	PRP$
work_sveky7445vfatkdfpzvurqbhza	38	17	level	level	NN
work_sveky7445vfatkdfpzvurqbhza	38	18	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	38	19	receptiveness	receptiveness	NN
work_sveky7445vfatkdfpzvurqbhza	38	20	is	be	VBZ
work_sveky7445vfatkdfpzvurqbhza	38	21	associated	associate	VBN
work_sveky7445vfatkdfpzvurqbhza	38	22	with	with	IN
work_sveky7445vfatkdfpzvurqbhza	38	23	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	38	24	source	source	NN
work_sveky7445vfatkdfpzvurqbhza	38	25	from	from	IN
work_sveky7445vfatkdfpzvurqbhza	38	26	which	which	WDT
work_sveky7445vfatkdfpzvurqbhza	38	27	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	38	28	patient	patient	NN
work_sveky7445vfatkdfpzvurqbhza	38	29	’s	’s	POS
work_sveky7445vfatkdfpzvurqbhza	38	30	questions	question	NNS
work_sveky7445vfatkdfpzvurqbhza	38	31	originate	originate	VBP
work_sveky7445vfatkdfpzvurqbhza	38	32	.	.	.
work_sveky7445vfatkdfpzvurqbhza	39	1	HP6	hp6	NN
work_sveky7445vfatkdfpzvurqbhza	39	2	RELATIONSHIP	RELATIONSHIP	NNS
work_sveky7445vfatkdfpzvurqbhza	39	3	OF	of	IN
work_sveky7445vfatkdfpzvurqbhza	39	4	DIRECT	direct	NN
work_sveky7445vfatkdfpzvurqbhza	39	5	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	39	6	TO	to	IN
work_sveky7445vfatkdfpzvurqbhza	39	7	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	39	8	CONSUMER	consumer	NN
work_sveky7445vfatkdfpzvurqbhza	39	9	ADVERTISING	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	39	10	SPENDING	spending	NN
work_sveky7445vfatkdfpzvurqbhza	39	11	AND	and	CC
work_sveky7445vfatkdfpzvurqbhza	39	12	DRUG	drug	NN
work_sveky7445vfatkdfpzvurqbhza	39	13	PRICING	pricing	NN
work_sveky7445vfatkdfpzvurqbhza	39	14	FOR	for	IN
work_sveky7445vfatkdfpzvurqbhza	39	15	THE	the	DT
work_sveky7445vfatkdfpzvurqbhza	39	16	TOP	top	JJ
work_sveky7445vfatkdfpzvurqbhza	39	17	TWENTY	TWENTY	NNP
work_sveky7445vfatkdfpzvurqbhza	39	18	DRUGS	drugs	NN
work_sveky7445vfatkdfpzvurqbhza	39	19	FROM	from	IN
work_sveky7445vfatkdfpzvurqbhza	39	20	1997	1997	CD
work_sveky7445vfatkdfpzvurqbhza	39	21	TO	to	IN
work_sveky7445vfatkdfpzvurqbhza	39	22	2000	2000	CD
work_sveky7445vfatkdfpzvurqbhza	39	23	:	:	:
work_sveky7445vfatkdfpzvurqbhza	39	24	AN	an	DT
work_sveky7445vfatkdfpzvurqbhza	39	25	EXPLORATORY	EXPLORATORY	NNP
work_sveky7445vfatkdfpzvurqbhza	39	26	STUDY	STUDY	NNP
work_sveky7445vfatkdfpzvurqbhza	39	27	Parthan	Parthan	NNP
work_sveky7445vfatkdfpzvurqbhza	39	28	AG	AG	NNP
work_sveky7445vfatkdfpzvurqbhza	39	29	,	,	,
work_sveky7445vfatkdfpzvurqbhza	39	30	Anantharaman	Anantharaman	NNP
work_sveky7445vfatkdfpzvurqbhza	39	31	RT	RT	NNP
work_sveky7445vfatkdfpzvurqbhza	39	32	,	,	,
work_sveky7445vfatkdfpzvurqbhza	39	33	Shepherd	Shepherd	NNP
work_sveky7445vfatkdfpzvurqbhza	39	34	MD	MD	NNP
work_sveky7445vfatkdfpzvurqbhza	39	35	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	39	36	University	University	NNP
work_sveky7445vfatkdfpzvurqbhza	39	37	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	39	38	Texas	Texas	NNP
work_sveky7445vfatkdfpzvurqbhza	39	39	at	at	IN
work_sveky7445vfatkdfpzvurqbhza	39	40	Austin	Austin	NNP
work_sveky7445vfatkdfpzvurqbhza	39	41	,	,	,
work_sveky7445vfatkdfpzvurqbhza	39	42	Austin	Austin	NNP
work_sveky7445vfatkdfpzvurqbhza	39	43	,	,	,
work_sveky7445vfatkdfpzvurqbhza	39	44	TX	TX	NNP
work_sveky7445vfatkdfpzvurqbhza	39	45	,	,	,
work_sveky7445vfatkdfpzvurqbhza	39	46	USA	USA	NNP
work_sveky7445vfatkdfpzvurqbhza	39	47	There	there	EX
work_sveky7445vfatkdfpzvurqbhza	39	48	exists	exist	VBZ
work_sveky7445vfatkdfpzvurqbhza	39	49	an	an	DT
work_sveky7445vfatkdfpzvurqbhza	39	50	ongoing	ongoing	JJ
work_sveky7445vfatkdfpzvurqbhza	39	51	debate	debate	NN
work_sveky7445vfatkdfpzvurqbhza	39	52	regarding	regard	VBG
work_sveky7445vfatkdfpzvurqbhza	39	53	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	39	54	effect	effect	NN
work_sveky7445vfatkdfpzvurqbhza	39	55	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	39	56	direct	direct	JJ
work_sveky7445vfatkdfpzvurqbhza	39	57	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	39	58	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	39	59	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	39	60	consumer	consumer	NN
work_sveky7445vfatkdfpzvurqbhza	39	61	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	39	62	DTC	DTC	NNP
work_sveky7445vfatkdfpzvurqbhza	39	63	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	39	64	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	39	65	spending	spending	NN
work_sveky7445vfatkdfpzvurqbhza	39	66	on	on	IN
work_sveky7445vfatkdfpzvurqbhza	39	67	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	39	68	prices	price	NNS
work_sveky7445vfatkdfpzvurqbhza	39	69	.	.	.
work_sveky7445vfatkdfpzvurqbhza	40	1	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	40	2	two	two	CD
work_sveky7445vfatkdfpzvurqbhza	40	3	opposite	opposite	JJ
work_sveky7445vfatkdfpzvurqbhza	40	4	views	view	NNS
work_sveky7445vfatkdfpzvurqbhza	40	5	are	be	VBP
work_sveky7445vfatkdfpzvurqbhza	40	6	:	:	:
work_sveky7445vfatkdfpzvurqbhza	40	7	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	40	8	a	a	LS
work_sveky7445vfatkdfpzvurqbhza	40	9	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	40	10	increase	increase	NN
work_sveky7445vfatkdfpzvurqbhza	40	11	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	40	12	DTC	dtc	NN
work_sveky7445vfatkdfpzvurqbhza	40	13	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	40	14	spending	spending	NN
work_sveky7445vfatkdfpzvurqbhza	40	15	would	would	MD
work_sveky7445vfatkdfpzvurqbhza	40	16	be	be	VB
work_sveky7445vfatkdfpzvurqbhza	40	17	added	add	VBN
work_sveky7445vfatkdfpzvurqbhza	40	18	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	40	19	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	40	20	prices	price	NNS
work_sveky7445vfatkdfpzvurqbhza	40	21	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	40	22	b	b	LS
work_sveky7445vfatkdfpzvurqbhza	40	23	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	40	24	DTC	dtc	NN
work_sveky7445vfatkdfpzvurqbhza	40	25	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	40	26	would	would	MD
work_sveky7445vfatkdfpzvurqbhza	40	27	increase	increase	VB
work_sveky7445vfatkdfpzvurqbhza	40	28	competition	competition	NN
work_sveky7445vfatkdfpzvurqbhza	40	29	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	40	30	thus	thus	RB
work_sveky7445vfatkdfpzvurqbhza	40	31	reduce	reduce	VB
work_sveky7445vfatkdfpzvurqbhza	40	32	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	40	33	prices	price	NNS
work_sveky7445vfatkdfpzvurqbhza	40	34	.	.	.
work_sveky7445vfatkdfpzvurqbhza	41	1	OBJECTIVE	objective	JJ
work_sveky7445vfatkdfpzvurqbhza	41	2	:	:	:
work_sveky7445vfatkdfpzvurqbhza	41	3	Explore	explore	VB
work_sveky7445vfatkdfpzvurqbhza	41	4	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	41	5	relationship	relationship	NN
work_sveky7445vfatkdfpzvurqbhza	41	6	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	41	7	DTC	DTC	NNP
work_sveky7445vfatkdfpzvurqbhza	41	8	advertis-	advertis-	NNP
work_sveky7445vfatkdfpzvurqbhza	41	9	ing	ing	NN
work_sveky7445vfatkdfpzvurqbhza	41	10	spending	spending	NN
work_sveky7445vfatkdfpzvurqbhza	41	11	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	41	12	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	41	13	pricing	pricing	NN
work_sveky7445vfatkdfpzvurqbhza	41	14	for	for	IN
work_sveky7445vfatkdfpzvurqbhza	41	15	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	41	16	top	top	JJ
work_sveky7445vfatkdfpzvurqbhza	41	17	twenty	twenty	CD
work_sveky7445vfatkdfpzvurqbhza	41	18	drugs	drug	NNS
work_sveky7445vfatkdfpzvurqbhza	41	19	from	from	IN
work_sveky7445vfatkdfpzvurqbhza	41	20	1997	1997	CD
work_sveky7445vfatkdfpzvurqbhza	41	21	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	41	22	2000	2000	CD
work_sveky7445vfatkdfpzvurqbhza	41	23	.	.	.
work_sveky7445vfatkdfpzvurqbhza	42	1	METHODS	methods	JJ
work_sveky7445vfatkdfpzvurqbhza	42	2	:	:	:
work_sveky7445vfatkdfpzvurqbhza	42	3	Top	top	JJ
work_sveky7445vfatkdfpzvurqbhza	42	4	twenty	twenty	CD
work_sveky7445vfatkdfpzvurqbhza	42	5	drugs	drug	NNS
work_sveky7445vfatkdfpzvurqbhza	42	6	were	be	VBD
work_sveky7445vfatkdfpzvurqbhza	42	7	selected	select	VBN
work_sveky7445vfatkdfpzvurqbhza	42	8	on	on	IN
work_sveky7445vfatkdfpzvurqbhza	42	9	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	42	10	basis	basis	NN
work_sveky7445vfatkdfpzvurqbhza	42	11	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	42	12	their	-PRON-	PRP$
work_sveky7445vfatkdfpzvurqbhza	42	13	DTC	dtc	NN
work_sveky7445vfatkdfpzvurqbhza	42	14	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	42	15	spending	spending	NN
work_sveky7445vfatkdfpzvurqbhza	42	16	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	42	17	source	source	NN
work_sveky7445vfatkdfpzvurqbhza	42	18	:	:	:
work_sveky7445vfatkdfpzvurqbhza	42	19	Competitive	competitive	JJ
work_sveky7445vfatkdfpzvurqbhza	42	20	Media	Media	NNP
work_sveky7445vfatkdfpzvurqbhza	42	21	Reporting	Reporting	NNP
work_sveky7445vfatkdfpzvurqbhza	42	22	,	,	,
work_sveky7445vfatkdfpzvurqbhza	42	23	NY	NY	NNP
work_sveky7445vfatkdfpzvurqbhza	42	24	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	42	25	for	for	IN
work_sveky7445vfatkdfpzvurqbhza	42	26	1997	1997	CD
work_sveky7445vfatkdfpzvurqbhza	42	27	.	.	.
work_sveky7445vfatkdfpzvurqbhza	43	1	For	for	IN
work_sveky7445vfatkdfpzvurqbhza	43	2	analysis	analysis	NN
work_sveky7445vfatkdfpzvurqbhza	43	3	,	,	,
work_sveky7445vfatkdfpzvurqbhza	43	4	average	average	JJ
work_sveky7445vfatkdfpzvurqbhza	43	5	wholesale	wholesale	JJ
work_sveky7445vfatkdfpzvurqbhza	43	6	price	price	NN
work_sveky7445vfatkdfpzvurqbhza	43	7	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	43	8	AWP	AWP	NNP
work_sveky7445vfatkdfpzvurqbhza	43	9	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	43	10	per	per	IN
work_sveky7445vfatkdfpzvurqbhza	43	11	unit	unit	NN
work_sveky7445vfatkdfpzvurqbhza	43	12	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	43	13	used	use	VBN
work_sveky7445vfatkdfpzvurqbhza	43	14	from	from	IN
work_sveky7445vfatkdfpzvurqbhza	43	15	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	43	16	Blue	Blue	NNP
work_sveky7445vfatkdfpzvurqbhza	43	17	Book	Book	NNP
work_sveky7445vfatkdfpzvurqbhza	43	18	AWP	AWP	NNP
work_sveky7445vfatkdfpzvurqbhza	43	19	Unit	Unit	NNP
work_sveky7445vfatkdfpzvurqbhza	43	20	pricing	pricing	NN
work_sveky7445vfatkdfpzvurqbhza	43	21	.	.	.
work_sveky7445vfatkdfpzvurqbhza	44	1	For	for	IN
work_sveky7445vfatkdfpzvurqbhza	44	2	each	each	DT
work_sveky7445vfatkdfpzvurqbhza	44	3	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	44	4	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	44	5	top	top	JJ
work_sveky7445vfatkdfpzvurqbhza	44	6	twenty	twenty	CD
work_sveky7445vfatkdfpzvurqbhza	44	7	drugs	drug	NNS
work_sveky7445vfatkdfpzvurqbhza	44	8	,	,	,
work_sveky7445vfatkdfpzvurqbhza	44	9	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	44	10	following	follow	VBG
work_sveky7445vfatkdfpzvurqbhza	44	11	trend	trend	NN
work_sveky7445vfatkdfpzvurqbhza	44	12	graphs	graph	NNS
work_sveky7445vfatkdfpzvurqbhza	44	13	were	be	VBD
work_sveky7445vfatkdfpzvurqbhza	44	14	plotted	plot	VBN
work_sveky7445vfatkdfpzvurqbhza	44	15	for	for	IN
work_sveky7445vfatkdfpzvurqbhza	44	16	1997	1997	CD
work_sveky7445vfatkdfpzvurqbhza	44	17	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	44	18	2000	2000	CD
work_sveky7445vfatkdfpzvurqbhza	44	19	:	:	:
work_sveky7445vfatkdfpzvurqbhza	44	20	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	44	21	a	a	LS
work_sveky7445vfatkdfpzvurqbhza	44	22	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	44	23	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	44	24	total	total	JJ
work_sveky7445vfatkdfpzvurqbhza	44	25	DTC	DTC	NNP
work_sveky7445vfatkdfpzvurqbhza	44	26	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	44	27	spending	spending	NN
work_sveky7445vfatkdfpzvurqbhza	44	28	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	44	29	per	per	IN
work_sveky7445vfatkdfpzvurqbhza	44	30	unit	unit	NN
work_sveky7445vfatkdfpzvurqbhza	44	31	price	price	NN
work_sveky7445vfatkdfpzvurqbhza	44	32	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	44	33	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	44	34	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	44	35	;	;	:
work_sveky7445vfatkdfpzvurqbhza	44	36	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	44	37	b	b	LS
work_sveky7445vfatkdfpzvurqbhza	44	38	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	44	39	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	44	40	percent	percent	NN
work_sveky7445vfatkdfpzvurqbhza	44	41	changes	change	VBZ
work_sveky7445vfatkdfpzvurqbhza	44	42	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	44	43	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	44	44	DTC	DTC	NNP
work_sveky7445vfatkdfpzvurqbhza	44	45	advertis-	advertis-	NN
work_sveky7445vfatkdfpzvurqbhza	44	46	ing	ing	NN
work_sveky7445vfatkdfpzvurqbhza	44	47	spending	spending	NN
work_sveky7445vfatkdfpzvurqbhza	44	48	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	44	49	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	44	50	price	price	NN
work_sveky7445vfatkdfpzvurqbhza	44	51	.	.	.
work_sveky7445vfatkdfpzvurqbhza	45	1	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	45	2	percent	percent	NN
work_sveky7445vfatkdfpzvurqbhza	45	3	change	change	NN
work_sveky7445vfatkdfpzvurqbhza	45	4	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	45	5	DTC	DTC	NNP
work_sveky7445vfatkdfpzvurqbhza	45	6	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	45	7	spending	spending	NN
work_sveky7445vfatkdfpzvurqbhza	45	8	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	45	9	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	45	10	price	price	NN
work_sveky7445vfatkdfpzvurqbhza	45	11	for	for	IN
work_sveky7445vfatkdfpzvurqbhza	45	12	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	45	13	year	year	NN
work_sveky7445vfatkdfpzvurqbhza	45	14	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	45	15	calculated	calculate	VBN
work_sveky7445vfatkdfpzvurqbhza	45	16	as	as	IN
work_sveky7445vfatkdfpzvurqbhza	45	17	percent	percent	NN
work_sveky7445vfatkdfpzvurqbhza	45	18	change	change	NN
work_sveky7445vfatkdfpzvurqbhza	45	19	from	from	IN
work_sveky7445vfatkdfpzvurqbhza	45	20	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	45	21	previous	previous	JJ
work_sveky7445vfatkdfpzvurqbhza	45	22	year	year	NN
work_sveky7445vfatkdfpzvurqbhza	45	23	.	.	.
work_sveky7445vfatkdfpzvurqbhza	46	1	RESULTS	RESULTS	NNP
work_sveky7445vfatkdfpzvurqbhza	46	2	:	:	:
work_sveky7445vfatkdfpzvurqbhza	46	3	Only	only	RB
work_sveky7445vfatkdfpzvurqbhza	46	4	sildenafil	sildenafil	NN
work_sveky7445vfatkdfpzvurqbhza	46	5	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	46	6	Viagra	Viagra	NNP
work_sveky7445vfatkdfpzvurqbhza	46	7	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	46	8	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	46	9	sibutramine	sibutramine	VB
work_sveky7445vfatkdfpzvurqbhza	46	10	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	46	11	Meridia	Meridia	NNP
work_sveky7445vfatkdfpzvurqbhza	46	12	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	46	13	showed	show	VBD
work_sveky7445vfatkdfpzvurqbhza	46	14	an	an	DT
work_sveky7445vfatkdfpzvurqbhza	46	15	increase	increase	NN
work_sveky7445vfatkdfpzvurqbhza	46	16	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	46	17	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	46	18	actual	actual	JJ
work_sveky7445vfatkdfpzvurqbhza	46	19	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	46	20	price	price	NN
work_sveky7445vfatkdfpzvurqbhza	46	21	with	with	IN
work_sveky7445vfatkdfpzvurqbhza	46	22	an	an	DT
work_sveky7445vfatkdfpzvurqbhza	46	23	increase	increase	NN
work_sveky7445vfatkdfpzvurqbhza	46	24	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	46	25	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	46	26	DTC	dtc	NN
work_sveky7445vfatkdfpzvurqbhza	46	27	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	46	28	spending	spending	NN
work_sveky7445vfatkdfpzvurqbhza	46	29	.	.	.
work_sveky7445vfatkdfpzvurqbhza	47	1	However	however	RB
work_sveky7445vfatkdfpzvurqbhza	47	2	,	,	,
work_sveky7445vfatkdfpzvurqbhza	47	3	for	for	IN
work_sveky7445vfatkdfpzvurqbhza	47	4	these	these	DT
work_sveky7445vfatkdfpzvurqbhza	47	5	two	two	CD
work_sveky7445vfatkdfpzvurqbhza	47	6	drugs	drug	NNS
work_sveky7445vfatkdfpzvurqbhza	47	7	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	47	8	year	year	NN
work_sveky7445vfatkdfpzvurqbhza	47	9	2000	2000	CD
work_sveky7445vfatkdfpzvurqbhza	47	10	,	,	,
work_sveky7445vfatkdfpzvurqbhza	47	11	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	47	12	percent	percent	NN
work_sveky7445vfatkdfpzvurqbhza	47	13	change	change	NN
work_sveky7445vfatkdfpzvurqbhza	47	14	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	47	15	DTC	DTC	NNP
work_sveky7445vfatkdfpzvurqbhza	47	16	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	47	17	spending	spending	NN
work_sveky7445vfatkdfpzvurqbhza	47	18	decreased	decrease	VBD
work_sveky7445vfatkdfpzvurqbhza	47	19	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	47	20	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	47	21	percent	percent	NN
work_sveky7445vfatkdfpzvurqbhza	47	22	change	change	NN
work_sveky7445vfatkdfpzvurqbhza	47	23	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	47	24	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	47	25	price	price	NN
work_sveky7445vfatkdfpzvurqbhza	47	26	increased	increase	VBD
work_sveky7445vfatkdfpzvurqbhza	47	27	.	.	.
work_sveky7445vfatkdfpzvurqbhza	48	1	No	no	DT
work_sveky7445vfatkdfpzvurqbhza	48	2	trend	trend	NN
work_sveky7445vfatkdfpzvurqbhza	48	3	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	48	4	evident	evident	JJ
work_sveky7445vfatkdfpzvurqbhza	48	5	from	from	IN
work_sveky7445vfatkdfpzvurqbhza	48	6	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	48	7	graphs	graphs	NN
work_sveky7445vfatkdfpzvurqbhza	48	8	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	48	9	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	48	10	other	other	JJ
work_sveky7445vfatkdfpzvurqbhza	48	11	eighteen	eighteen	CD
work_sveky7445vfatkdfpzvurqbhza	48	12	drugs	drug	NNS
work_sveky7445vfatkdfpzvurqbhza	48	13	.	.	.
work_sveky7445vfatkdfpzvurqbhza	49	1	On	on	IN
work_sveky7445vfatkdfpzvurqbhza	49	2	an	an	DT
work_sveky7445vfatkdfpzvurqbhza	49	3	average	average	JJ
work_sveky7445vfatkdfpzvurqbhza	49	4	DTC	dtc	NN
work_sveky7445vfatkdfpzvurqbhza	49	5	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	49	6	spending	spending	NN
work_sveky7445vfatkdfpzvurqbhza	49	7	for	for	IN
work_sveky7445vfatkdfpzvurqbhza	49	8	most	most	JJS
work_sveky7445vfatkdfpzvurqbhza	49	9	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	49	10	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	49	11	drugs	drug	NNS
work_sveky7445vfatkdfpzvurqbhza	49	12	decreased	decrease	VBD
work_sveky7445vfatkdfpzvurqbhza	49	13	with	with	IN
work_sveky7445vfatkdfpzvurqbhza	49	14	time	time	NN
work_sveky7445vfatkdfpzvurqbhza	49	15	while	while	IN
work_sveky7445vfatkdfpzvurqbhza	49	16	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	49	17	prices	price	NNS
work_sveky7445vfatkdfpzvurqbhza	49	18	continued	continue	VBD
work_sveky7445vfatkdfpzvurqbhza	49	19	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	49	20	increase	increase	VB
work_sveky7445vfatkdfpzvurqbhza	49	21	.	.	.
work_sveky7445vfatkdfpzvurqbhza	50	1	CONCLUSION	conclusion	NN
work_sveky7445vfatkdfpzvurqbhza	50	2	:	:	:
work_sveky7445vfatkdfpzvurqbhza	50	3	Results	result	NNS
work_sveky7445vfatkdfpzvurqbhza	50	4	indicate	indicate	VBP
work_sveky7445vfatkdfpzvurqbhza	50	5	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	50	6	very	very	RB
work_sveky7445vfatkdfpzvurqbhza	50	7	weak	weak	JJ
work_sveky7445vfatkdfpzvurqbhza	50	8	relation-	relation-	NN
work_sveky7445vfatkdfpzvurqbhza	50	9	ship	ship	NN
work_sveky7445vfatkdfpzvurqbhza	50	10	between	between	IN
work_sveky7445vfatkdfpzvurqbhza	50	11	DTC	DTC	NNP
work_sveky7445vfatkdfpzvurqbhza	50	12	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	50	13	spending	spending	NN
work_sveky7445vfatkdfpzvurqbhza	50	14	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	50	15	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	50	16	prices	price	NNS
work_sveky7445vfatkdfpzvurqbhza	50	17	.	.	.
work_sveky7445vfatkdfpzvurqbhza	51	1	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	51	2	increase	increase	NN
work_sveky7445vfatkdfpzvurqbhza	51	3	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	51	4	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	51	5	price	price	NN
work_sveky7445vfatkdfpzvurqbhza	51	6	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	51	7	spite	spite	NN
work_sveky7445vfatkdfpzvurqbhza	51	8	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	51	9	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	51	10	decrease	decrease	NN
work_sveky7445vfatkdfpzvurqbhza	51	11	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	51	12	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	51	13	DTC	DTC	NNP
work_sveky7445vfatkdfpzvurqbhza	51	14	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	51	15	spending	spending	NN
work_sveky7445vfatkdfpzvurqbhza	51	16	contradicts	contradict	VBZ
work_sveky7445vfatkdfpzvurqbhza	51	17	both	both	CC
work_sveky7445vfatkdfpzvurqbhza	51	18	rationale	rationale	NN
work_sveky7445vfatkdfpzvurqbhza	51	19	i.e.	i.e.	FW
work_sveky7445vfatkdfpzvurqbhza	52	1	DTC	dtc	NN
work_sveky7445vfatkdfpzvurqbhza	52	2	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	52	3	spending	spending	NN
work_sveky7445vfatkdfpzvurqbhza	52	4	reduces	reduce	VBZ
work_sveky7445vfatkdfpzvurqbhza	52	5	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	52	6	price	price	NN
work_sveky7445vfatkdfpzvurqbhza	52	7	through	through	IN
work_sveky7445vfatkdfpzvurqbhza	52	8	competition	competition	NN
work_sveky7445vfatkdfpzvurqbhza	52	9	or	or	CC
work_sveky7445vfatkdfpzvurqbhza	52	10	increase	increase	NN
work_sveky7445vfatkdfpzvurqbhza	52	11	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	52	12	drug	drug	NN
work_sveky7445vfatkdfpzvurqbhza	52	13	price	price	NN
work_sveky7445vfatkdfpzvurqbhza	52	14	is	be	VBZ
work_sveky7445vfatkdfpzvurqbhza	52	15	due	due	JJ
work_sveky7445vfatkdfpzvurqbhza	52	16	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	52	17	increase	increase	VB
work_sveky7445vfatkdfpzvurqbhza	52	18	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	52	19	DTC	dtc	NN
work_sveky7445vfatkdfpzvurqbhza	52	20	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	52	21	spending	spending	NN
work_sveky7445vfatkdfpzvurqbhza	52	22	.	.	.
work_sveky7445vfatkdfpzvurqbhza	53	1	HP7	HP7	NNP
work_sveky7445vfatkdfpzvurqbhza	53	2	IMPACT	IMPACT	NNP
work_sveky7445vfatkdfpzvurqbhza	53	3	OF	of	IN
work_sveky7445vfatkdfpzvurqbhza	53	4	DIRECT	DIRECT	NNS
work_sveky7445vfatkdfpzvurqbhza	53	5	TO	to	IN
work_sveky7445vfatkdfpzvurqbhza	53	6	CONSUMER	consumer	NN
work_sveky7445vfatkdfpzvurqbhza	53	7	ADVERTISING	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	53	8	—	—	:
work_sveky7445vfatkdfpzvurqbhza	53	9	THE	the	DT
work_sveky7445vfatkdfpzvurqbhza	53	10	CONSUMER	consumer	NN
work_sveky7445vfatkdfpzvurqbhza	53	11	SEARCH	SEARCH	NNS
work_sveky7445vfatkdfpzvurqbhza	53	12	FOR	for	IN
work_sveky7445vfatkdfpzvurqbhza	53	13	INFORMATION	INFORMATION	NNP
work_sveky7445vfatkdfpzvurqbhza	53	14	Belazi	Belazi	NNP
work_sveky7445vfatkdfpzvurqbhza	53	15	DT1	DT1	NNP
work_sveky7445vfatkdfpzvurqbhza	53	16	,	,	,
work_sveky7445vfatkdfpzvurqbhza	53	17	Crawford	Crawford	NNP
work_sveky7445vfatkdfpzvurqbhza	53	18	A2	A2	NNP
work_sveky7445vfatkdfpzvurqbhza	53	19	,	,	,
work_sveky7445vfatkdfpzvurqbhza	53	20	Pizzi	Pizzi	NNP
work_sveky7445vfatkdfpzvurqbhza	53	21	L2	L2	NNP
work_sveky7445vfatkdfpzvurqbhza	53	22	1Thomas	1Thomas	NNP
work_sveky7445vfatkdfpzvurqbhza	53	23	Jefferson	Jefferson	NNP
work_sveky7445vfatkdfpzvurqbhza	53	24	University	University	NNP
work_sveky7445vfatkdfpzvurqbhza	53	25	&	&	CC
work_sveky7445vfatkdfpzvurqbhza	53	26	Abbott	Abbott	NNP
work_sveky7445vfatkdfpzvurqbhza	53	27	Laboratories	Laboratories	NNP
work_sveky7445vfatkdfpzvurqbhza	53	28	,	,	,
work_sveky7445vfatkdfpzvurqbhza	53	29	Philadelphia	Philadelphia	NNP
work_sveky7445vfatkdfpzvurqbhza	53	30	,	,	,
work_sveky7445vfatkdfpzvurqbhza	53	31	PA	PA	NNP
work_sveky7445vfatkdfpzvurqbhza	53	32	,	,	,
work_sveky7445vfatkdfpzvurqbhza	53	33	USA	USA	NNP
work_sveky7445vfatkdfpzvurqbhza	53	34	;	;	:
work_sveky7445vfatkdfpzvurqbhza	53	35	2Thomas	2thomas	CD
work_sveky7445vfatkdfpzvurqbhza	53	36	Jefferson	Jefferson	NNP
work_sveky7445vfatkdfpzvurqbhza	53	37	University	University	NNP
work_sveky7445vfatkdfpzvurqbhza	53	38	,	,	,
work_sveky7445vfatkdfpzvurqbhza	53	39	Philadelphia	Philadelphia	NNP
work_sveky7445vfatkdfpzvurqbhza	53	40	,	,	,
work_sveky7445vfatkdfpzvurqbhza	53	41	PA	PA	NNP
work_sveky7445vfatkdfpzvurqbhza	53	42	,	,	,
work_sveky7445vfatkdfpzvurqbhza	53	43	USA	USA	NNP
work_sveky7445vfatkdfpzvurqbhza	53	44	OBJECTIVE	OBJECTIVE	NNP
work_sveky7445vfatkdfpzvurqbhza	53	45	:	:	:
work_sveky7445vfatkdfpzvurqbhza	53	46	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	53	47	purpose	purpose	NN
work_sveky7445vfatkdfpzvurqbhza	53	48	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	53	49	this	this	DT
work_sveky7445vfatkdfpzvurqbhza	53	50	study	study	NN
work_sveky7445vfatkdfpzvurqbhza	53	51	is	be	VBZ
work_sveky7445vfatkdfpzvurqbhza	53	52	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	53	53	identify	identify	VB
work_sveky7445vfatkdfpzvurqbhza	53	54	factors	factor	NNS
work_sveky7445vfatkdfpzvurqbhza	53	55	associated	associate	VBN
work_sveky7445vfatkdfpzvurqbhza	53	56	with	with	IN
work_sveky7445vfatkdfpzvurqbhza	53	57	consumers	consumer	NNS
work_sveky7445vfatkdfpzvurqbhza	53	58	’	’	POS
work_sveky7445vfatkdfpzvurqbhza	53	59	seeking	seek	VBG
work_sveky7445vfatkdfpzvurqbhza	53	60	various	various	JJ
work_sveky7445vfatkdfpzvurqbhza	53	61	infor-	infor-	JJ
work_sveky7445vfatkdfpzvurqbhza	53	62	mation	mation	NN
work_sveky7445vfatkdfpzvurqbhza	53	63	sources	source	NNS
work_sveky7445vfatkdfpzvurqbhza	53	64	about	about	IN
work_sveky7445vfatkdfpzvurqbhza	53	65	medications	medication	NNS
work_sveky7445vfatkdfpzvurqbhza	53	66	sought	seek	VBN
work_sveky7445vfatkdfpzvurqbhza	53	67	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	53	68	response	response	NN
work_sveky7445vfatkdfpzvurqbhza	53	69	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	53	70	direct	direct	VB
work_sveky7445vfatkdfpzvurqbhza	53	71	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	53	72	consumer	consumer	NN
work_sveky7445vfatkdfpzvurqbhza	53	73	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	53	74	.	.	.
work_sveky7445vfatkdfpzvurqbhza	54	1	METHODS	METHODS	NNP
work_sveky7445vfatkdfpzvurqbhza	54	2	:	:	:
work_sveky7445vfatkdfpzvurqbhza	54	3	In	in	IN
work_sveky7445vfatkdfpzvurqbhza	54	4	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	54	5	spring	spring	NN
work_sveky7445vfatkdfpzvurqbhza	54	6	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	54	7	summer	summer	NN
work_sveky7445vfatkdfpzvurqbhza	54	8	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	54	9	1999	1999	CD
work_sveky7445vfatkdfpzvurqbhza	54	10	,	,	,
work_sveky7445vfatkdfpzvurqbhza	54	11	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	54	12	FDA	FDA	NNP
work_sveky7445vfatkdfpzvurqbhza	54	13	,	,	,
work_sveky7445vfatkdfpzvurqbhza	54	14	Division	Division	NNP
work_sveky7445vfatkdfpzvurqbhza	54	15	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	54	16	Drug	Drug	NNP
work_sveky7445vfatkdfpzvurqbhza	54	17	Marketing	Marketing	NNP
work_sveky7445vfatkdfpzvurqbhza	54	18	,	,	,
work_sveky7445vfatkdfpzvurqbhza	54	19	Advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	54	20	,	,	,
work_sveky7445vfatkdfpzvurqbhza	54	21	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	54	22	Commu-	Commu-	NNP
work_sveky7445vfatkdfpzvurqbhza	54	23	nication	nication	NN
work_sveky7445vfatkdfpzvurqbhza	54	24	conducted	conduct	VBD
work_sveky7445vfatkdfpzvurqbhza	54	25	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	54	26	national	national	JJ
work_sveky7445vfatkdfpzvurqbhza	54	27	telephone	telephone	NN
work_sveky7445vfatkdfpzvurqbhza	54	28	survey	survey	NN
work_sveky7445vfatkdfpzvurqbhza	54	29	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	54	30	adults	adult	NNS
work_sveky7445vfatkdfpzvurqbhza	54	31	regarding	regard	VBG
work_sveky7445vfatkdfpzvurqbhza	54	32	Direct	Direct	NNP
work_sveky7445vfatkdfpzvurqbhza	54	33	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	54	34	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	54	35	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	54	36	Consumer	Consumer	NNP
work_sveky7445vfatkdfpzvurqbhza	54	37	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	54	38	DTC	DTC	NNP
work_sveky7445vfatkdfpzvurqbhza	54	39	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	54	40	promotion	promotion	NN
work_sveky7445vfatkdfpzvurqbhza	54	41	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	54	42	prescription	prescription	NN
work_sveky7445vfatkdfpzvurqbhza	54	43	drugs	drug	NNS
work_sveky7445vfatkdfpzvurqbhza	54	44	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	54	45	its	-PRON-	PRP$
work_sveky7445vfatkdfpzvurqbhza	54	46	effects	effect	NNS
work_sveky7445vfatkdfpzvurqbhza	54	47	on	on	IN
work_sveky7445vfatkdfpzvurqbhza	54	48	visits	visit	NNS
work_sveky7445vfatkdfpzvurqbhza	54	49	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	54	50	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	54	51	doctor	doctor	NN
work_sveky7445vfatkdfpzvurqbhza	54	52	.	.	.
work_sveky7445vfatkdfpzvurqbhza	55	1	In	in	IN
work_sveky7445vfatkdfpzvurqbhza	55	2	addition	addition	NN
work_sveky7445vfatkdfpzvurqbhza	55	3	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	55	4	consumer	consumer	NN
work_sveky7445vfatkdfpzvurqbhza	55	5	attitudes	attitude	NNS
work_sveky7445vfatkdfpzvurqbhza	55	6	,	,	,
work_sveky7445vfatkdfpzvurqbhza	55	7	opinions	opinion	NNS
work_sveky7445vfatkdfpzvurqbhza	55	8	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	55	9	responses	response	NNS
work_sveky7445vfatkdfpzvurqbhza	55	10	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	55	11	direct	direct	VB
work_sveky7445vfatkdfpzvurqbhza	55	12	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	55	13	consumer	consumer	NN
work_sveky7445vfatkdfpzvurqbhza	55	14	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	55	15	,	,	,
work_sveky7445vfatkdfpzvurqbhza	55	16	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	55	17	survey	survey	NN
work_sveky7445vfatkdfpzvurqbhza	55	18	also	also	RB
work_sveky7445vfatkdfpzvurqbhza	55	19	elicited	elicit	VBD
work_sveky7445vfatkdfpzvurqbhza	55	20	responses	response	NNS
work_sveky7445vfatkdfpzvurqbhza	55	21	regarding	regard	VBG
work_sveky7445vfatkdfpzvurqbhza	55	22	consumer	consumer	NN
work_sveky7445vfatkdfpzvurqbhza	55	23	utilization	utilization	NN
work_sveky7445vfatkdfpzvurqbhza	55	24	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	55	25	information	information	NN
work_sveky7445vfatkdfpzvurqbhza	55	26	sources	source	NNS
work_sveky7445vfatkdfpzvurqbhza	55	27	such	such	JJ
work_sveky7445vfatkdfpzvurqbhza	55	28	as	as	IN
work_sveky7445vfatkdfpzvurqbhza	55	29	reference	reference	NN
work_sveky7445vfatkdfpzvurqbhza	55	30	books	book	NNS
work_sveky7445vfatkdfpzvurqbhza	55	31	,	,	,
work_sveky7445vfatkdfpzvurqbhza	55	32	800-telelphone	800-telelphone	CD
work_sveky7445vfatkdfpzvurqbhza	55	33	number	number	NN
work_sveky7445vfatkdfpzvurqbhza	55	34	,	,	,
work_sveky7445vfatkdfpzvurqbhza	55	35	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	55	36	health	health	NN
work_sveky7445vfatkdfpzvurqbhza	55	37	care	care	NN
work_sveky7445vfatkdfpzvurqbhza	55	38	providers	provider	NNS
work_sveky7445vfatkdfpzvurqbhza	55	39	.	.	.
work_sveky7445vfatkdfpzvurqbhza	56	1	There	there	EX
work_sveky7445vfatkdfpzvurqbhza	56	2	were	be	VBD
work_sveky7445vfatkdfpzvurqbhza	56	3	1081	1081	CD
work_sveky7445vfatkdfpzvurqbhza	56	4	total	total	JJ
work_sveky7445vfatkdfpzvurqbhza	56	5	respon-	respon-	NNP
work_sveky7445vfatkdfpzvurqbhza	56	6	dents	dent	NNS
work_sveky7445vfatkdfpzvurqbhza	56	7	,	,	,
work_sveky7445vfatkdfpzvurqbhza	56	8	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	56	9	whom	whom	WP
work_sveky7445vfatkdfpzvurqbhza	56	10	769	769	CD
work_sveky7445vfatkdfpzvurqbhza	56	11	completed	complete	VBD
work_sveky7445vfatkdfpzvurqbhza	56	12	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	56	13	required	require	VBN
work_sveky7445vfatkdfpzvurqbhza	56	14	questions	question	NNS
work_sveky7445vfatkdfpzvurqbhza	56	15	regarding	regard	VBG
work_sveky7445vfatkdfpzvurqbhza	56	16	information	information	NN
work_sveky7445vfatkdfpzvurqbhza	56	17	sources	source	NNS
work_sveky7445vfatkdfpzvurqbhza	56	18	.	.	.
work_sveky7445vfatkdfpzvurqbhza	57	1	Chi	Chi	NNP
work_sveky7445vfatkdfpzvurqbhza	57	2	Square	Square	NNP
work_sveky7445vfatkdfpzvurqbhza	57	3	analysis	analysis	NN
work_sveky7445vfatkdfpzvurqbhza	57	4	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	57	5	used	use	VBN
work_sveky7445vfatkdfpzvurqbhza	57	6	to	to	TO
work_sveky7445vfatkdfpzvurqbhza	57	7	assess	assess	VB
work_sveky7445vfatkdfpzvurqbhza	57	8	associations	association	NNS
work_sveky7445vfatkdfpzvurqbhza	57	9	between	between	IN
work_sveky7445vfatkdfpzvurqbhza	57	10	consumer	consumer	NN
work_sveky7445vfatkdfpzvurqbhza	57	11	demographic	demographic	JJ
work_sveky7445vfatkdfpzvurqbhza	57	12	information	information	NN
work_sveky7445vfatkdfpzvurqbhza	57	13	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	57	14	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	57	15	different	different	JJ
work_sveky7445vfatkdfpzvurqbhza	57	16	types	type	NNS
work_sveky7445vfatkdfpzvurqbhza	57	17	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	57	18	informational	informational	JJ
work_sveky7445vfatkdfpzvurqbhza	57	19	resources	resource	NNS
work_sveky7445vfatkdfpzvurqbhza	57	20	that	that	WDT
work_sveky7445vfatkdfpzvurqbhza	57	21	consumers	consumer	NNS
work_sveky7445vfatkdfpzvurqbhza	57	22	used	use	VBN
work_sveky7445vfatkdfpzvurqbhza	57	23	after	after	IN
work_sveky7445vfatkdfpzvurqbhza	57	24	exposure	exposure	NN
work_sveky7445vfatkdfpzvurqbhza	57	25	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	57	26	direct	direct	JJ
work_sveky7445vfatkdfpzvurqbhza	57	27	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	57	28	consumer	consumer	NN
work_sveky7445vfatkdfpzvurqbhza	57	29	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	57	30	.	.	.
work_sveky7445vfatkdfpzvurqbhza	58	1	RESULTS	RESULTS	NNP
work_sveky7445vfatkdfpzvurqbhza	58	2	:	:	:
work_sveky7445vfatkdfpzvurqbhza	58	3	The	the	DT
work_sveky7445vfatkdfpzvurqbhza	58	4	analysis	analysis	NN
work_sveky7445vfatkdfpzvurqbhza	58	5	showed	show	VBD
work_sveky7445vfatkdfpzvurqbhza	58	6	significant	significant	JJ
work_sveky7445vfatkdfpzvurqbhza	58	7	associations	association	NNS
work_sveky7445vfatkdfpzvurqbhza	58	8	(	(	-LRB-
work_sveky7445vfatkdfpzvurqbhza	58	9	p	p	DT
work_sveky7445vfatkdfpzvurqbhza	58	10	£	£	$
work_sveky7445vfatkdfpzvurqbhza	58	11	0.05	0.05	CD
work_sveky7445vfatkdfpzvurqbhza	58	12	)	)	-RRB-
work_sveky7445vfatkdfpzvurqbhza	58	13	between	between	IN
work_sveky7445vfatkdfpzvurqbhza	58	14	gender	gender	NN
work_sveky7445vfatkdfpzvurqbhza	58	15	,	,	,
work_sveky7445vfatkdfpzvurqbhza	58	16	race	race	NN
work_sveky7445vfatkdfpzvurqbhza	58	17	,	,	,
work_sveky7445vfatkdfpzvurqbhza	58	18	education	education	NN
work_sveky7445vfatkdfpzvurqbhza	58	19	,	,	,
work_sveky7445vfatkdfpzvurqbhza	58	20	health	health	NN
work_sveky7445vfatkdfpzvurqbhza	58	21	status	status	NN
work_sveky7445vfatkdfpzvurqbhza	58	22	,	,	,
work_sveky7445vfatkdfpzvurqbhza	58	23	self	self	NN
work_sveky7445vfatkdfpzvurqbhza	58	24	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	58	25	perceived	perceive	VBN
work_sveky7445vfatkdfpzvurqbhza	58	26	knowledge	knowledge	NN
work_sveky7445vfatkdfpzvurqbhza	58	27	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	58	28	health	health	NN
work_sveky7445vfatkdfpzvurqbhza	58	29	,	,	,
work_sveky7445vfatkdfpzvurqbhza	58	30	prescription	prescription	NN
work_sveky7445vfatkdfpzvurqbhza	58	31	medication	medication	NN
work_sveky7445vfatkdfpzvurqbhza	58	32	use	use	NN
work_sveky7445vfatkdfpzvurqbhza	58	33	,	,	,
work_sveky7445vfatkdfpzvurqbhza	58	34	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	58	35	internet	internet	NN
work_sveky7445vfatkdfpzvurqbhza	58	36	use	use	NN
work_sveky7445vfatkdfpzvurqbhza	58	37	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	58	38	many	many	JJ
work_sveky7445vfatkdfpzvurqbhza	58	39	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	58	40	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	58	41	following	follow	VBG
work_sveky7445vfatkdfpzvurqbhza	58	42	information	information	NN
work_sveky7445vfatkdfpzvurqbhza	58	43	resources	resource	NNS
work_sveky7445vfatkdfpzvurqbhza	58	44	:	:	:
work_sveky7445vfatkdfpzvurqbhza	58	45	reference	reference	NN
work_sveky7445vfatkdfpzvurqbhza	58	46	books	book	NNS
work_sveky7445vfatkdfpzvurqbhza	58	47	,	,	,
work_sveky7445vfatkdfpzvurqbhza	58	48	asking	ask	VBG
work_sveky7445vfatkdfpzvurqbhza	58	49	friends	friend	NNS
work_sveky7445vfatkdfpzvurqbhza	58	50	/	/	SYM
work_sveky7445vfatkdfpzvurqbhza	58	51	neighbors	neighbor	NNS
work_sveky7445vfatkdfpzvurqbhza	58	52	,	,	,
work_sveky7445vfatkdfpzvurqbhza	58	53	800-telephone	800-telephone	CD
work_sveky7445vfatkdfpzvurqbhza	58	54	number	number	NN
work_sveky7445vfatkdfpzvurqbhza	58	55	,	,	,
work_sveky7445vfatkdfpzvurqbhza	58	56	primary	primary	JJ
work_sveky7445vfatkdfpzvurqbhza	58	57	doctor	doctor	NN
work_sveky7445vfatkdfpzvurqbhza	58	58	,	,	,
work_sveky7445vfatkdfpzvurqbhza	58	59	pharmacist	pharmacist	NN
work_sveky7445vfatkdfpzvurqbhza	58	60	,	,	,
work_sveky7445vfatkdfpzvurqbhza	58	61	specialist	specialist	NN
work_sveky7445vfatkdfpzvurqbhza	58	62	,	,	,
work_sveky7445vfatkdfpzvurqbhza	58	63	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	58	64	nurse	nurse	NN
work_sveky7445vfatkdfpzvurqbhza	58	65	.	.	.
work_sveky7445vfatkdfpzvurqbhza	59	1	Across	across	IN
work_sveky7445vfatkdfpzvurqbhza	59	2	all	all	DT
work_sveky7445vfatkdfpzvurqbhza	59	3	information	information	NN
work_sveky7445vfatkdfpzvurqbhza	59	4	sources	source	NNS
work_sveky7445vfatkdfpzvurqbhza	59	5	,	,	,
work_sveky7445vfatkdfpzvurqbhza	59	6	female	female	JJ
work_sveky7445vfatkdfpzvurqbhza	59	7	gender	gender	NN
work_sveky7445vfatkdfpzvurqbhza	59	8	,	,	,
work_sveky7445vfatkdfpzvurqbhza	59	9	decreased	decrease	VBD
work_sveky7445vfatkdfpzvurqbhza	59	10	health	health	NN
work_sveky7445vfatkdfpzvurqbhza	59	11	status	status	NN
work_sveky7445vfatkdfpzvurqbhza	59	12	,	,	,
work_sveky7445vfatkdfpzvurqbhza	59	13	low	low	JJ
work_sveky7445vfatkdfpzvurqbhza	59	14	education	education	NN
work_sveky7445vfatkdfpzvurqbhza	59	15	,	,	,
work_sveky7445vfatkdfpzvurqbhza	59	16	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	59	17	higher	high	JJR
work_sveky7445vfatkdfpzvurqbhza	59	18	than	than	IN
work_sveky7445vfatkdfpzvurqbhza	59	19	average	average	JJ
work_sveky7445vfatkdfpzvurqbhza	59	20	medica-	medica-	NN
work_sveky7445vfatkdfpzvurqbhza	59	21	tion	tion	NN
work_sveky7445vfatkdfpzvurqbhza	59	22	use	use	NN
work_sveky7445vfatkdfpzvurqbhza	59	23	were	be	VBD
work_sveky7445vfatkdfpzvurqbhza	59	24	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	59	25	variables	variable	NNS
work_sveky7445vfatkdfpzvurqbhza	59	26	that	that	WDT
work_sveky7445vfatkdfpzvurqbhza	59	27	had	have	VBD
work_sveky7445vfatkdfpzvurqbhza	59	28	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	59	29	strongest	strong	JJS
work_sveky7445vfatkdfpzvurqbhza	59	30	associ-	associ-	NN
work_sveky7445vfatkdfpzvurqbhza	59	31	ations	ation	NNS
work_sveky7445vfatkdfpzvurqbhza	59	32	.	.	.
work_sveky7445vfatkdfpzvurqbhza	60	1	A	a	DT
work_sveky7445vfatkdfpzvurqbhza	60	2	model	model	NN
work_sveky7445vfatkdfpzvurqbhza	60	3	was	be	VBD
work_sveky7445vfatkdfpzvurqbhza	60	4	developed	develop	VBN
work_sveky7445vfatkdfpzvurqbhza	60	5	depicting	depict	VBG
work_sveky7445vfatkdfpzvurqbhza	60	6	the	the	DT
work_sveky7445vfatkdfpzvurqbhza	60	7	associations	association	NNS
work_sveky7445vfatkdfpzvurqbhza	60	8	between	between	IN
work_sveky7445vfatkdfpzvurqbhza	60	9	these	these	DT
work_sveky7445vfatkdfpzvurqbhza	60	10	findings	finding	NNS
work_sveky7445vfatkdfpzvurqbhza	60	11	.	.	.
work_sveky7445vfatkdfpzvurqbhza	61	1	Results	result	NNS
work_sveky7445vfatkdfpzvurqbhza	61	2	pertaining	pertain	VBG
work_sveky7445vfatkdfpzvurqbhza	61	3	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	61	4	specific	specific	JJ
work_sveky7445vfatkdfpzvurqbhza	61	5	sources	source	NNS
work_sveky7445vfatkdfpzvurqbhza	61	6	will	will	MD
work_sveky7445vfatkdfpzvurqbhza	61	7	be	be	VB
work_sveky7445vfatkdfpzvurqbhza	61	8	presented	present	VBN
work_sveky7445vfatkdfpzvurqbhza	61	9	.	.	.
work_sveky7445vfatkdfpzvurqbhza	62	1	CONCLUSIONS	conclusion	NNS
work_sveky7445vfatkdfpzvurqbhza	62	2	:	:	:
work_sveky7445vfatkdfpzvurqbhza	62	3	This	this	DT
work_sveky7445vfatkdfpzvurqbhza	62	4	study	study	NN
work_sveky7445vfatkdfpzvurqbhza	62	5	evaluated	evaluate	VBD
work_sveky7445vfatkdfpzvurqbhza	62	6	how	how	WRB
work_sveky7445vfatkdfpzvurqbhza	62	7	different	different	JJ
work_sveky7445vfatkdfpzvurqbhza	62	8	consumers	consumer	NNS
work_sveky7445vfatkdfpzvurqbhza	62	9	seek	seek	VBP
work_sveky7445vfatkdfpzvurqbhza	62	10	information	information	NN
work_sveky7445vfatkdfpzvurqbhza	62	11	from	from	IN
work_sveky7445vfatkdfpzvurqbhza	62	12	different	different	JJ
work_sveky7445vfatkdfpzvurqbhza	62	13	sources	source	NNS
work_sveky7445vfatkdfpzvurqbhza	62	14	as	as	IN
work_sveky7445vfatkdfpzvurqbhza	62	15	a	a	DT
work_sveky7445vfatkdfpzvurqbhza	62	16	result	result	NN
work_sveky7445vfatkdfpzvurqbhza	62	17	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	62	18	direct	direct	JJ
work_sveky7445vfatkdfpzvurqbhza	62	19	to	to	IN
work_sveky7445vfatkdfpzvurqbhza	62	20	consumer	consumer	NN
work_sveky7445vfatkdfpzvurqbhza	62	21	advertising	advertising	NN
work_sveky7445vfatkdfpzvurqbhza	62	22	.	.	.
work_sveky7445vfatkdfpzvurqbhza	63	1	This	this	DT
work_sveky7445vfatkdfpzvurqbhza	63	2	study	study	NN
work_sveky7445vfatkdfpzvurqbhza	63	3	will	will	MD
work_sveky7445vfatkdfpzvurqbhza	63	4	assist	assist	VB
work_sveky7445vfatkdfpzvurqbhza	63	5	those	those	DT
work_sveky7445vfatkdfpzvurqbhza	63	6	interested	interested	JJ
work_sveky7445vfatkdfpzvurqbhza	63	7	in	in	IN
work_sveky7445vfatkdfpzvurqbhza	63	8	identifying	identify	VBG
work_sveky7445vfatkdfpzvurqbhza	63	9	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	63	10	further	further	JJ
work_sveky7445vfatkdfpzvurqbhza	63	11	educat-	educat-	NN
work_sveky7445vfatkdfpzvurqbhza	63	12	ing	e	VBG
work_sveky7445vfatkdfpzvurqbhza	63	13	consumers	consumer	NNS
work_sveky7445vfatkdfpzvurqbhza	63	14	about	about	IN
work_sveky7445vfatkdfpzvurqbhza	63	15	their	-PRON-	PRP$
work_sveky7445vfatkdfpzvurqbhza	63	16	health	health	NN
work_sveky7445vfatkdfpzvurqbhza	63	17	and	and	CC
work_sveky7445vfatkdfpzvurqbhza	63	18	novel	novel	NN
work_sveky7445vfatkdfpzvurqbhza	63	19	treatments	treatment	NNS
work_sveky7445vfatkdfpzvurqbhza	63	20	or	or	CC
work_sveky7445vfatkdfpzvurqbhza	63	21	therapies	therapy	NNS
work_sveky7445vfatkdfpzvurqbhza	63	22	.	.	.
work_sveky7445vfatkdfpzvurqbhza	64	1	HP8	HP8	NNP
work_sveky7445vfatkdfpzvurqbhza	64	2	FDA	FDA	NNP
work_sveky7445vfatkdfpzvurqbhza	64	3	REGULATORY	REGULATORY	NNP
work_sveky7445vfatkdfpzvurqbhza	64	4	ACTIONS	actions	NN
work_sveky7445vfatkdfpzvurqbhza	64	5	AGAINST	against	RB
work_sveky7445vfatkdfpzvurqbhza	64	6	MISLEADING	mislead	VBG
work_sveky7445vfatkdfpzvurqbhza	64	7	OR	or	CC
work_sveky7445vfatkdfpzvurqbhza	64	8	UNSUBSTANTIATED	UNSUBSTANTIATED	NNP
work_sveky7445vfatkdfpzvurqbhza	64	9	ECONOMIC	ECONOMIC	NNP
work_sveky7445vfatkdfpzvurqbhza	64	10	AND	and	CC
work_sveky7445vfatkdfpzvurqbhza	64	11	QUALITY	quality	NN
work_sveky7445vfatkdfpzvurqbhza	64	12	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	64	13	OF	of	IN
work_sveky7445vfatkdfpzvurqbhza	64	14	-	-	HYPH
work_sveky7445vfatkdfpzvurqbhza	64	15	LIFE	life	NN
work_sveky7445vfatkdfpzvurqbhza	64	16	CLAIMS	claim	NNS
work_sveky7445vfatkdfpzvurqbhza	64	17	:	:	:
work_sveky7445vfatkdfpzvurqbhza	64	18	AN	an	DT
work_sveky7445vfatkdfpzvurqbhza	64	19	ANALYSIS	analysis	NN
work_sveky7445vfatkdfpzvurqbhza	64	20	OF	of	IN
work_sveky7445vfatkdfpzvurqbhza	64	21	WARNING	warning	NN
work_sveky7445vfatkdfpzvurqbhza	64	22	LETTERS	letter	NNS
work_sveky7445vfatkdfpzvurqbhza	64	23	AND	and	CC
work_sveky7445vfatkdfpzvurqbhza	64	24	NOTICES	notices	NN
work_sveky7445vfatkdfpzvurqbhza	64	25	OF	of	IN
work_sveky7445vfatkdfpzvurqbhza	64	26	VIOLATION	VIOLATION	NNP
work_sveky7445vfatkdfpzvurqbhza	64	27	Stewart	Stewart	NNP
work_sveky7445vfatkdfpzvurqbhza	64	28	KA	KA	NNP
work_sveky7445vfatkdfpzvurqbhza	64	29	,	,	,
work_sveky7445vfatkdfpzvurqbhza	64	30	Neumann	Neumann	NNP
work_sveky7445vfatkdfpzvurqbhza	64	31	PJ	PJ	NNP
work_sveky7445vfatkdfpzvurqbhza	64	32	Harvard	Harvard	NNP
work_sveky7445vfatkdfpzvurqbhza	64	33	School	School	NNP
work_sveky7445vfatkdfpzvurqbhza	64	34	of	of	IN
work_sveky7445vfatkdfpzvurqbhza	64	35	Public	Public	NNP
work_sveky7445vfatkdfpzvurqbhza	64	36	Health	Health	NNP
work_sveky7445vfatkdfpzvurqbhza	64	37	,	,	,
work_sveky7445vfatkdfpzvurqbhza	64	38	Boston	Boston	NNP
work_sveky7445vfatkdfpzvurqbhza	64	39	,	,	,
work_sveky7445vfatkdfpzvurqbhza	64	40	MA	MA	NNP
work_sveky7445vfatkdfpzvurqbhza	64	41	,	,	,
work_sveky7445vfatkdfpzvurqbhza	64	42	USA	USA	NNP